candidate_genes,disease,celltype,y,user_question,full_query
"['CFI', 'SEC23A', 'ECHDC2', 'GTF2I', 'OAZ3']",Sjogren syndrome,acinar cell of salivary gland,GTF2I,"Among the genes CFI, SEC23A, ECHDC2, GTF2I, and OAZ3, which one is most specifically expressed in salivary gland acinar cells, making it the best candidate target for Sjogren's syndrome?","Among the genes CFI, SEC23A, ECHDC2, GTF2I, and OAZ3, which one is most specifically expressed in salivary gland acinar cells, making it the best candidate target for Sjogren's syndrome? Identify the verified therapeutic targets for Sjögren syndrome and extract their cell-type–specific embeddings from PINNACLE. Next, determine which targets overlap with acinar cell–activated genes in the salivary gland from PINNACLE, as these constitute cell-type–specific targets for Sjögren syndrome. Compute the average embedding for this overlapping set and calculate the cosine similarity between this average and each target-specific embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['HLA-B', 'MASP2', 'KLHL20', 'DLGAP2', 'TECPR1']",Sjogren syndrome,acinar cell of salivary gland,HLA-B,"Among the candidate genes HLA-B, MASP2, KLHL20, DLGAP2, and TECPR1, which one exhibits the highest cell-type specificity in salivary gland acinar cells, thereby representing the most promising target for therapeutic intervention in Sjögren's syndrome?","Among the candidate genes HLA-B, MASP2, KLHL20, DLGAP2, and TECPR1, which one exhibits the highest cell-type specificity in salivary gland acinar cells, thereby representing the most promising target for therapeutic intervention in Sjögren's syndrome? Identify verified therapeutic targets for Sjogren syndrome and extract their cell-type–specific embeddings from PINNACLE. Determine which of these targets overlap with acinar cell-activated genes in the salivary gland, thereby defining the cell-type–specific targets. Compute the average embedding for this overlapping set and calculate the cosine similarity between this average and each individual target. If one gene shows markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['STAU1', 'MIDEAS', 'PSKH2', 'MEIG1', 'FCGRT']",Sjogren syndrome,acinar cell of salivary gland,FCGRT,"Which gene among STAU1, MIDEAS, PSKH2, MEIG1, and FCGRT exhibits the highest cell-type specificity in salivary gland acinar cells, making it the most promising candidate for targeting Sjögren's syndrome?","Which gene among STAU1, MIDEAS, PSKH2, MEIG1, and FCGRT exhibits the highest cell-type specificity in salivary gland acinar cells, making it the most promising candidate for targeting Sjögren's syndrome? Retrieve the verified therapeutic targets for Sjogren syndrome along with their cell-type–specific embeddings from PINNACLE. Identify the overlap between these targets and salivary gland acinar cell-activated genes, defining the cell-type–specific targets for Sjogren syndrome. Compute the average embedding for this overlapping gene set and calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CHMP1A', 'CHRM3', 'AEN', 'RBM11', 'BTF3L4']",Sjogren syndrome,acinar cell of salivary gland,CHRM3,"Among the genes CHMP1A, CHRM3, AEN, RBM11, and BTF3L4, which one exhibits the highest expression specificity in salivary gland acinar cells as a candidate target for Sjögren's syndrome?","Among the genes CHMP1A, CHRM3, AEN, RBM11, and BTF3L4, which one exhibits the highest expression specificity in salivary gland acinar cells as a candidate target for Sjögren's syndrome? Identify the confirmed therapeutic targets for Sjogren syndrome and retrieve their cell-type–specific embeddings from the PINNACLE database, along with the embeddings for acinar cell-activated genes in the salivary gland. Determine the intersection of these two gene sets to define the candidate cell-type–specific targets, compute their average embedding as a reference, and then calculate the cosine similarity between this reference and each individual target’s embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['AKT1', 'C11orf65', 'SARS2', 'CLIP3', 'IFNAR1']",Sjogren syndrome,acinar cell of salivary gland,IFNAR1,"Which gene—AKT1, C11orf65, SARS2, CLIP3, or IFNAR1—demonstrates the most specific expression in salivary gland acinar cells, making it the best candidate for targeting in Sjogren’s syndrome?","Which gene—AKT1, C11orf65, SARS2, CLIP3, or IFNAR1—demonstrates the most specific expression in salivary gland acinar cells, making it the best candidate for targeting in Sjogren’s syndrome? Identify the verified therapeutic targets for Sjögren syndrome and obtain their cell-type–specific embeddings from the PINNACLE dataset. Next, compare these targets with acinar cell–activated genes in the salivary gland (as defined by PINNACLE) to identify overlapping, acinar-specific targets. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between the reference and each individual target. If one gene shows substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological significance."
"['GOLGA8F', 'SYNM', 'TSPAN2', 'PYM1', 'SOCS6']",Sjogren syndrome,acinar cell of salivary gland,PYM1,"Among the genes GOLGA8F, SYNM, TSPAN2, PYM1, and SOCS6, which one exhibits the highest acinar cell-specific expression in the salivary gland, making it the most suitable candidate for targeting in Sjögren’s syndrome?","Among the genes GOLGA8F, SYNM, TSPAN2, PYM1, and SOCS6, which one exhibits the highest acinar cell-specific expression in the salivary gland, making it the most suitable candidate for targeting in Sjögren’s syndrome? Determine the confirmed therapeutic targets for Sjogren syndrome and extract their cell-type–specific embeddings from the PINNACLE database. Identify the overlap between these targets and the acinar cell-activated genes in the salivary gland present in PINNACLE. Compute the average embedding of this overlapping set as a reference vector, then calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ABHD17C', 'HLA-DPA1', 'ATG101', 'SUMO1P1', 'DYDC1']",Sjogren syndrome,acinar cell of salivary gland,HLA-DPA1,"Among ABHD17C, HLA-DPA1, ATG101, SUMO1P1, and DYDC1, which gene demonstrates the highest cell-type specificity within salivary gland acinar cells for addressing Sjögren's syndrome?","Among ABHD17C, HLA-DPA1, ATG101, SUMO1P1, and DYDC1, which gene demonstrates the highest cell-type specificity within salivary gland acinar cells for addressing Sjögren's syndrome? Identify validated therapeutic targets for Sjögren syndrome and obtain their cell-type-specific embeddings from PINNACLE. Next, retrieve the acinar cell-activated gene embeddings from the salivary gland in PINNACLE and identify the overlapping genes between this set and the targets, defining these as the cell-type-specific targets for Sjögren syndrome. Compute the average embedding for these overlapping genes and then calculate the cosine similarity between this composite vector and each individual target embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MPP2', 'PPP2R3A', 'RCN1', 'LRRC4C', 'MYO1A']",Sjogren syndrome,acinar cell of salivary gland,RCN1,"Which gene—MPP2, PPP2R3A, RCN1, LRRC4C, or MYO1A—exhibits the most selective expression in salivary gland acinar cells, thereby representing a promising target for Sjogren’s syndrome?","Which gene—MPP2, PPP2R3A, RCN1, LRRC4C, or MYO1A—exhibits the most selective expression in salivary gland acinar cells, thereby representing a promising target for Sjogren’s syndrome? Identify verified therapeutic targets for Sjögren syndrome and obtain their cell‐type–specific embeddings from PINNACLE. Next, determine which genes activated in salivary gland acinar cells overlap with these targets. Compute the average embedding of the overlapping targets, then calculate the cosine similarity between this reference and each individual target. If one gene exhibits a substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological significance."
"['ARPC5L', 'TMEM8B', 'DDX6', 'LEF1-AS1', 'GIMAP6']",Sjogren syndrome,acinar cell of salivary gland,DDX6,"Among ARPC5L, TMEM8B, DDX6, LEF1-AS1, and GIMAP6, which gene exhibits the highest specificity for acinar cells in the salivary gland, making it the most suitable candidate for targeting in Sjogren's syndrome?","Among ARPC5L, TMEM8B, DDX6, LEF1-AS1, and GIMAP6, which gene exhibits the highest specificity for acinar cells in the salivary gland, making it the most suitable candidate for targeting in Sjogren's syndrome? Identify the verified therapeutic targets for Sjögren syndrome and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which acinar cell–activated genes from the salivary gland, as identified in PINNACLE, overlap with these targets. Compute the average embedding for this overlapping set and calculate the cosine similarity of each individual target's embedding relative to the average. If one gene exhibits a markedly higher cosine similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['ITGA1', 'PAPOLA', 'FKBP1A', 'AKAP1', 'NPRL3']",Sjogren syndrome,acinar cell of salivary gland,FKBP1A,"Which gene among ITGA1, PAPOLA, FKBP1A, AKAP1, and NPRL3 exhibits the highest cell-type specificity in salivary gland acinar cells, thereby representing the most promising target for Sjögren syndrome?","Which gene among ITGA1, PAPOLA, FKBP1A, AKAP1, and NPRL3 exhibits the highest cell-type specificity in salivary gland acinar cells, thereby representing the most promising target for Sjögren syndrome? Identify the validated therapeutic targets for Sjogren syndrome and retrieve their corresponding cell-type–specific embeddings from the PINNACLE database. Next, determine the overlap between these targets and the genes activated in salivary gland acinar cells to define the cell-type–specific targets for Sjogren syndrome. Compute the average embedding for this overlapping set, then calculate the cosine similarity between the average and the individual target embeddings. If one gene shows a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['HMGB3P1', 'GNA12', 'PTF1A', 'IMPDH2', 'SAP30L']",Sjogren syndrome,acinar cell of salivary gland,IMPDH2,"Among HMGB3P1, GNA12, PTF1A, IMPDH2, and SAP30L, which gene exhibits the highest expression specificity in salivary gland acinar cells, thereby making it the most promising candidate for targeting Sjogren syndrome?","Among HMGB3P1, GNA12, PTF1A, IMPDH2, and SAP30L, which gene exhibits the highest expression specificity in salivary gland acinar cells, thereby making it the most promising candidate for targeting Sjogren syndrome? Identify the verified therapeutic targets for Sjögren syndrome and extract their cell-type–specific embeddings from PINNACLE. Next, determine which acinar cell–activated genes in the salivary gland from PINNACLE overlap with these targets, thereby defining the cell-type–specific targets for Sjögren syndrome. Compute the average embedding of these overlapping targets as a reference, and calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a significantly higher cosine similarity compared to the others, nominate it as the top candidate, and provide a brief, evidence-based rationale for its biological relevance."
"['DUXAP9', 'HLA-DRA', 'ARL6IP1', 'PDE4B', 'RHO']",Sjogren syndrome,acinar cell of salivary gland,HLA-DRA,"Among the genes DUXAP9, HLA-DRA, ARL6IP1, PDE4B, and RHO, which one exhibits the highest specificity in salivary gland acinar cells, thereby making it the most promising target for therapeutic intervention in Sjogren's syndrome?","Among the genes DUXAP9, HLA-DRA, ARL6IP1, PDE4B, and RHO, which one exhibits the highest specificity in salivary gland acinar cells, thereby making it the most promising target for therapeutic intervention in Sjogren's syndrome? Determine the verified therapeutic targets for Sjögren syndrome and extract their cell-type-specific embeddings from PINNACLE. Identify which acinar cell-activated genes in the salivary gland profile from PINNACLE overlap with these targets, thereby defining the cell-type-specific targets for Sjögren syndrome. Compute the average embedding for this overlapping set as a reference, calculate the cosine similarity between the reference and each individual target, and if one gene shows significantly higher similarity than the rest, nominate it as the top candidate with a concise, evidence-based rationale for its biological relevance."
"['ZNF625', 'THAP12', 'CTSS', 'OLFM1', 'PDGFRA']",Sjogren syndrome,acinar cell of salivary gland,CTSS,"Among the genes ZNF625, THAP12, CTSS, OLFM1, and PDGFRA, which gene shows the highest cell-type specific expression in salivary gland acinar cells, making it the most promising target for Sjögren syndrome intervention?","Among the genes ZNF625, THAP12, CTSS, OLFM1, and PDGFRA, which gene shows the highest cell-type specific expression in salivary gland acinar cells, making it the most promising target for Sjögren syndrome intervention? Using validated therapeutic targets for Sjögren syndrome, extract their cell-type–specific embeddings from PINNACLE. Next, identify the overlapping set between these targets and acinar cell–activated genes in the salivary gland present in PINNACLE. For these overlapping genes, compute the average embedding as a reference and calculate the cosine similarity between this reference vector and each gene's embedding. If one gene displays significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['RMND1', 'STAT1', 'C1orf174', 'PPP1R9B', 'NTRK3']",Sjogren syndrome,acinar cell of salivary gland,STAT1,"Among RMND1, STAT1, C1orf174, PPP1R9B, and NTRK3, which gene demonstrates the highest specificity in salivary gland acinar cells and would serve as the best target candidate for Sjogren's syndrome?","Among RMND1, STAT1, C1orf174, PPP1R9B, and NTRK3, which gene demonstrates the highest specificity in salivary gland acinar cells and would serve as the best target candidate for Sjogren's syndrome? Identify all verified therapeutic targets for Sjogren syndrome and obtain their corresponding cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with genes activated in salivary gland acinar cells in PINNACLE, as these represent the cell-type–specific candidates for Sjogren syndrome. Calculate the average embedding for this overlapping set and compute the cosine similarity between this average and each individual target embedding. If one gene exhibits a notably higher similarity than the others, designate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['GABARAP', 'CD40', 'POU4F2', 'RAB23', 'CNDP1']",Sjogren syndrome,acinar cell of salivary gland,CD40,"Among the genes GABARAP, CD40, POU4F2, RAB23, and CNDP1, which one shows the highest specificity in acinar cells of the salivary gland, making it the most promising target for Sjögren syndrome?","Among the genes GABARAP, CD40, POU4F2, RAB23, and CNDP1, which one shows the highest specificity in acinar cells of the salivary gland, making it the most promising target for Sjögren syndrome? Identify the validated therapeutic targets for Sjögren's syndrome and retrieve their cell-type-specific embeddings from PINNACLE. Next, determine which of these targets overlap with the acinar cell–activated genes in the salivary gland from PINNACLE, considering this overlapping set as the cell-type-specific targets. Calculate the average embedding of these overlapping genes, then compute the cosine similarity between this average and each individual target's embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['AKT1', 'MIF', 'CCDC183', 'SIRT7', 'PDLIM1']",Sjogren syndrome,acinar cell of salivary gland,MIF,"Among the genes AKT1, MIF, CCDC183, SIRT7, and PDLIM1, which exhibits the highest cell-type-specific expression in salivary gland acinar cells that could be targeted in Sjögren syndrome?","Among the genes AKT1, MIF, CCDC183, SIRT7, and PDLIM1, which exhibits the highest cell-type-specific expression in salivary gland acinar cells that could be targeted in Sjögren syndrome? Identify the verified therapeutic targets for Sjögren syndrome and obtain their cell-type–specific embeddings from PINNACLE. Then, determine the intersection between these targets and genes activated in acinar cells of the salivary gland in PINNACLE. Compute the average embedding of the overlapping set as a reference, and calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PPIA', 'DELE1', 'SPOUT1', 'NUP210', 'RNF141']",Sjogren syndrome,acinar cell of salivary gland,PPIA,"Among the genes PPIA, DELE1, SPOUT1, NUP210, and RNF141, which one exhibits the highest acinar cell-specific expression in the salivary gland relevant to Sjogren’s syndrome?","Among the genes PPIA, DELE1, SPOUT1, NUP210, and RNF141, which one exhibits the highest acinar cell-specific expression in the salivary gland relevant to Sjogren’s syndrome? Identify validated therapeutic targets for Sjögren syndrome and extract their cell-type–specific embeddings from PINNACLE. Next, determine which acinar cell–specific activated genes from the salivary gland in PINNACLE overlap with these targets to define the relevant cell-type–specific subset. Compute the average embedding of this subset as a reference and calculate cosine similarity between this reference and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['HLA-DPB1', 'MARCHF5', 'MYOZ3', 'TSPYL6', 'CLIC1']",Sjogren syndrome,acinar cell of salivary gland,HLA-DPB1,"Which gene—HLA-DPB1, MARCHF5, MYOZ3, TSPYL6, or CLIC1—exhibits the most specific expression in salivary gland acinar cells, thereby representing the most promising target for therapeutic intervention in Sjogren syndrome?","Which gene—HLA-DPB1, MARCHF5, MYOZ3, TSPYL6, or CLIC1—exhibits the most specific expression in salivary gland acinar cells, thereby representing the most promising target for therapeutic intervention in Sjogren syndrome? Using the PINNACLE dataset, identify the validated therapeutic targets for Sjogren syndrome and extract their cell-type-specific embeddings. Next, determine which of these targets overlap with acinar cell-activated genes in the salivary gland to generate a refined set of cell-type–specific candidate targets. Compute the average embedding for these candidates and, subsequently, calculate the cosine similarity between this average and each individual gene’s embedding. If a single gene exhibits a markedly higher similarity compared to the others, nominate it as the top candidate and provide a brief evidence-based rationale for its biological relevance."
"['CTTNBP2NL', 'JAK1', 'DHX16', 'STRADA', 'TIE1']",Sjogren syndrome,acinar cell of salivary gland,JAK1,"Which gene among CTTNBP2NL, JAK1, DHX16, STRADA, and TIE1 exhibits the highest cell-type-specific expression in salivary gland acinar cells, indicating its potential as a therapeutic target for Sjögren syndrome?","Which gene among CTTNBP2NL, JAK1, DHX16, STRADA, and TIE1 exhibits the highest cell-type-specific expression in salivary gland acinar cells, indicating its potential as a therapeutic target for Sjögren syndrome? Identify validated therapeutic targets for Sjogren syndrome and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which acinar cell–activated salivary gland genes in PINNACLE overlap with these targets. For this overlapping set, compute the average embedding as a reference, then calculate the cosine similarity between this reference and each individual target. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['IARS1', 'SMARCC2', 'WBP4', 'TBC1D10C', 'ZDHHC22']",Sjogren syndrome,acinar cell of salivary gland,SMARCC2,"Among IARS1, SMARCC2, WBP4, TBC1D10C, and ZDHHC22, which gene exhibits the highest cell-type specificity for acinar cells in the salivary gland, making it the most promising target for addressing Sjögren's syndrome?","Among IARS1, SMARCC2, WBP4, TBC1D10C, and ZDHHC22, which gene exhibits the highest cell-type specificity for acinar cells in the salivary gland, making it the most promising target for addressing Sjögren's syndrome? Identify experimentally validated therapeutic targets for Sjogren syndrome and extract their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and genes activated in salivary gland acinar cells from PINNACLE. Compute the average embedding of the overlapping set as a reference profile and calculate the cosine similarity between this reference and each individual target gene. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['CTSS', 'TOB2', 'LAIR1', 'RIPPLY3', 'FFAR3']",Sjogren syndrome,iga plasma cell,CTSS,"Among the genes CTSS, TOB2, LAIR1, RIPPLY3, and FFAR3, which exhibits the highest cell-type-specific expression in IgA plasma cells for potential therapeutic targeting of Sjogren syndrome?","Among the genes CTSS, TOB2, LAIR1, RIPPLY3, and FFAR3, which exhibits the highest cell-type-specific expression in IgA plasma cells for potential therapeutic targeting of Sjogren syndrome? Identify validated therapeutic targets for Sjögren syndrome and extract their cell-type–specific embeddings from the PINNACLE dataset. Determine which of the IgA plasma cell–activated genes in PINNACLE intersect with these targets to define cell-type–specific therapeutic candidates for Sjögren syndrome. Next, compute the average embedding of this overlapping gene set as a reference and calculate the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MIF', 'TULP4', 'HYI', 'EMP1', 'CDK15']",Sjogren syndrome,iga plasma cell,MIF,"Among the genes MIF, TULP4, HYI, EMP1, and CDK15, which shows the highest cell-type specificity in IgA plasma cells, making it the most promising target for therapeutic intervention in Sjögren syndrome?","Among the genes MIF, TULP4, HYI, EMP1, and CDK15, which shows the highest cell-type specificity in IgA plasma cells, making it the most promising target for therapeutic intervention in Sjögren syndrome? Identify the validated therapeutic targets for Sjögren syndrome and extract their cell-type-specific embeddings from PINNACLE. Next, identify which of the Iga plasma cell-activated genes in PINNACLE overlap with these targets. For this overlapping gene set, calculate the average embedding to serve as a reference, then compute the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['CXCR1', 'GAR1', 'NSMCE2', 'PPIA', 'BOP1']",Sjogren syndrome,iga plasma cell,PPIA,"Among the genes CXCR1, GAR1, NSMCE2, PPIA, and BOP1, which one exhibits the highest specificity in IgA plasma cells for targeting Sjögren’s syndrome?","Among the genes CXCR1, GAR1, NSMCE2, PPIA, and BOP1, which one exhibits the highest specificity in IgA plasma cells for targeting Sjögren’s syndrome? Identify the validated therapeutic targets for Sjogren syndrome and obtain their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which of the Iga plasma cell-activated genes in PINNACLE overlap with these validated targets to define the cell-type–specific therapeutic targets for Sjogren syndrome. Compute the average embedding for this overlapping set as a reference, and then calculate the cosine similarity between this reference and the individual embeddings. If one gene exhibits a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['DCP2', 'TNFAIP3', 'GJA1', 'TFPI', 'CHMP2A']",Sjogren syndrome,iga plasma cell,TNFAIP3,"Which gene—DCP2, TNFAIP3, GJA1, TFPI, or CHMP2A—exhibits the highest cell-type specificity in IgA plasma cells for targeting Sjögren syndrome?","Which gene—DCP2, TNFAIP3, GJA1, TFPI, or CHMP2A—exhibits the highest cell-type specificity in IgA plasma cells for targeting Sjögren syndrome? Identify all verified therapeutic targets for Sjogren syndrome and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which IgA plasma cell–activated genes in PINNACLE overlap with these targets to define the cell-type–specific targets for Sjogren syndrome. Compute the average embedding of this overlapping set, and then calculate the cosine similarity between this average and each individual target. If one gene exhibits a significantly higher similarity compared to the others, nominate it as the leading candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TIMM9', 'DUSP15', 'MXRA8', 'SRRT', 'HLA-B']",Sjogren syndrome,iga plasma cell,HLA-B,"Among the genes TIMM9, DUSP15, MXRA8, SRRT, and HLA-B, which exhibits the highest cell-type specificity in IgA plasma cells for targeting in Sjögren's syndrome?","Among the genes TIMM9, DUSP15, MXRA8, SRRT, and HLA-B, which exhibits the highest cell-type specificity in IgA plasma cells for targeting in Sjögren's syndrome? Identify validated therapeutic targets for Sjögren syndrome and retrieve their cell-type specific embeddings from PINNACLE. Determine the overlap between these targets and the IgA plasma cell–activated genes in PINNACLE. Compute the average embedding for this overlapping set and calculate the cosine similarity between the average and each individual target. If one gene shows a distinctly higher similarity, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NHP2', 'GRIA4', 'AP2S1', 'CTSS', 'CCT6A']",Sjogren syndrome,iga plasma cell,CTSS,"Which gene among NHP2, GRIA4, AP2S1, CTSS, and CCT6A exhibits the most specific expression in IgA plasma cells, making it the ideal candidate for targeted intervention in Sjögren syndrome?","Which gene among NHP2, GRIA4, AP2S1, CTSS, and CCT6A exhibits the most specific expression in IgA plasma cells, making it the ideal candidate for targeted intervention in Sjögren syndrome? Identify validated therapeutic targets for Sjogren syndrome and retrieve their cell type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the iga plasma cell-activated genes in PINNACLE to define cell type-specific therapeutic targets. Compute the average embedding for these overlapping genes and calculate the cosine similarity between this averaged embedding and each individual target embedding. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CLUH', 'ANO9', 'PDLIM2', 'CELF3', 'MIF']",Sjogren syndrome,iga plasma cell,MIF,"Which gene among CLUH, ANO9, PDLIM2, CELF3, and MIF exhibits the highest expression specificity in IgA plasma cells, making it the most promising candidate for targeting Sjögren syndrome?","Which gene among CLUH, ANO9, PDLIM2, CELF3, and MIF exhibits the highest expression specificity in IgA plasma cells, making it the most promising candidate for targeting Sjögren syndrome? Identify the verified therapeutic targets for Sjogren syndrome and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of the IgA plasma cell-activated genes in PINNACLE overlap with these targets to define the cell-type–specific candidate set. Compute the average embedding for these overlapping genes, then calculate the cosine similarity between this average and each individual target. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['CNPY4', 'TNFAIP3', 'TECR', 'STX17', 'YME1L1']",Sjogren syndrome,iga plasma cell,TNFAIP3,"Among the genes CNPY4, TNFAIP3, TECR, STX17, and YME1L1, which one exhibits the highest cell-type specificity in IgA plasma cells, making it the most promising target for Sjögren syndrome?","Among the genes CNPY4, TNFAIP3, TECR, STX17, and YME1L1, which one exhibits the highest cell-type specificity in IgA plasma cells, making it the most promising target for Sjögren syndrome? Using PINNACLE data, first identify the verified therapeutic targets for Sjogren syndrome and retrieve their cell-type–specific embeddings. Next, determine the overlap between these targets and the set of IgA plasma cell–activated genes in PINNACLE; this overlapping group represents the cell-type–specific targets. Compute the average embedding for this group and then calculate the cosine similarity between this reference vector and each individual target embedding. If one gene exhibits substantially higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based rationale for its biological relevance."
"['EHHADH', 'PPIA', 'SLC5A1', 'ARF1', 'WT1-AS']",Sjogren syndrome,iga plasma cell,PPIA,"Among the genes EHHADH, PPIA, SLC5A1, ARF1, and WT1-AS, which one exhibits the highest cell-type specificity in IgA plasma cells, making it the most suitable target for therapeutic intervention in Sjogren syndrome?","Among the genes EHHADH, PPIA, SLC5A1, ARF1, and WT1-AS, which one exhibits the highest cell-type specificity in IgA plasma cells, making it the most suitable target for therapeutic intervention in Sjogren syndrome? Identify verified therapeutic targets for Sjögren syndrome and extract their cell-type–specific embeddings from PINNACLE. Next, determine which IGA plasma cell–activated genes from PINNACLE overlap with these targets to define a set of cell-type–specific targets for the disease. Compute the average embedding of this overlapping set and calculate the cosine similarity between this average and each individual target embedding. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['HLA-B', 'ZNF276', 'PORCN', 'SHANK3', 'KCNRG']",Sjogren syndrome,iga plasma cell,HLA-B,"Which gene among HLA-B, ZNF276, PORCN, SHANK3, and KCNRG exhibits the highest cell-type specificity in IgA plasma cells relevant to Sjögren's syndrome?","Which gene among HLA-B, ZNF276, PORCN, SHANK3, and KCNRG exhibits the highest cell-type specificity in IgA plasma cells relevant to Sjögren's syndrome? Identify the verified therapeutic targets for Sjögren syndrome and obtain their cell-type–specific embeddings from the PINNACLE resource. Next, determine which of these targets overlap with the Iga plasma cell-activated gene set in PINNACLE, and compute the average embedding of the overlapping genes as a reference. Finally, calculate the cosine similarity between this reference and the individual embeddings of the overlapping targets, and if one gene exhibits significantly higher similarity compared to the others, nominate it as the top candidate with a concise, evidence-based justification for its biological relevance."
"['TNFAIP3', 'GREM1', 'NECAB3', 'GUCY2D', 'CLTC']",Sjogren syndrome,iga plasma cell,TNFAIP3,"Which gene among TNFAIP3, GREM1, NECAB3, GUCY2D, and CLTC demonstrates the greatest cell-type specificity in IgA plasma cells, thereby representing the most promising target for therapeutic intervention in Sjögren's syndrome?","Which gene among TNFAIP3, GREM1, NECAB3, GUCY2D, and CLTC demonstrates the greatest cell-type specificity in IgA plasma cells, thereby representing the most promising target for therapeutic intervention in Sjögren's syndrome? Identify the verified therapeutic targets for Sjogren syndrome and extract their cell-type–specific embeddings from PINNACLE. Determine the overlap between these targets and the IGA plasma cell–activated genes in PINNACLE, defining this intersection as the cell-type–specific target set for Sjogren syndrome. Compute the average embedding for this set, then calculate the cosine similarity between this average and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['WBP2NL', 'PPY', 'CTSS', 'RIBC2', 'TNC']",Sjogren syndrome,iga plasma cell,CTSS,"Among the genes WBP2NL, PPY, CTSS, RIBC2, and TNC, which one exhibits the highest specificity for IgA-producing plasma cells, thereby making it the optimal candidate for targeting Sjogren syndrome?","Among the genes WBP2NL, PPY, CTSS, RIBC2, and TNC, which one exhibits the highest specificity for IgA-producing plasma cells, thereby making it the optimal candidate for targeting Sjogren syndrome? Identify the validated therapeutic targets for Sjögren syndrome and extract their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the Iga plasma cell-activated genes in PINNACLE to define the cell-type–specific targets for Sjögren syndrome. Compute the average embedding for this overlapping set as a reference, and then calculate the cosine similarity between this reference and each individual target's embedding. If one gene demonstrates significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TEKT4', 'HLA-B', 'OR14I1', 'CERS3', 'SP140']",Sjogren syndrome,iga plasma cell,HLA-B,"Among the genes TEKT4, HLA-B, OR14I1, CERS3, and SP140, which one exhibits the highest specificity of expression in IgA plasma cells and represents the most promising candidate for targeted intervention in Sjögren syndrome?","Among the genes TEKT4, HLA-B, OR14I1, CERS3, and SP140, which one exhibits the highest specificity of expression in IgA plasma cells and represents the most promising candidate for targeted intervention in Sjögren syndrome? Identify the verified therapeutic targets for Sjögren syndrome and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the Iga plasma cell–activated genes in PINNACLE to define the cell-type–specific targets for Sjögren syndrome. Compute the average embedding for this overlapping set and calculate the cosine similarity between this reference and each individual target’s embedding. If one candidate gene shows a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MIF', 'WFDC12', 'MRPL10', 'TACR3', 'DPPA4']",Sjogren syndrome,iga plasma cell,MIF,"Which gene among MIF, WFDC12, MRPL10, TACR3, and DPPA4 exhibits the highest cell-type specificity in IgA plasma cells as a target for Sjögren’s syndrome?","Which gene among MIF, WFDC12, MRPL10, TACR3, and DPPA4 exhibits the highest cell-type specificity in IgA plasma cells as a target for Sjögren’s syndrome? Identify the validated therapeutic targets for Sjogren syndrome and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with the IgA plasma cell–activated genes in PINNACLE. Compute the average embedding of this overlapping set, then calculate the cosine similarity between this average and the embedding of each target. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TRABD', 'PPIA', 'PALB2', 'ATP6V0E2', 'TTC21B']",Sjogren syndrome,iga plasma cell,PPIA,"Which gene—TRABD, PPIA, PALB2, ATP6V0E2, or TTC21B—exhibits the highest specificity of expression in IgA plasma cells, thereby representing the most promising target for Sjögren's syndrome?","Which gene—TRABD, PPIA, PALB2, ATP6V0E2, or TTC21B—exhibits the highest specificity of expression in IgA plasma cells, thereby representing the most promising target for Sjögren's syndrome? Identify the verified therapeutic targets for Sjogren syndrome and retrieve their cell-type–specific embeddings from the PINNACLE dataset. Determine the overlap between these targets and the IgA plasma cell–activated gene set in PINNACLE. Calculate the average embedding of this overlapping set as a reference, then compute the cosine similarity between the reference and each individual target. If a single gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PODXL', 'MIF', 'KMT2D', 'TIMM17B', 'BHLHE40']",Sjogren syndrome,iga plasma cell,MIF,"Which gene among PODXL, MIF, KMT2D, TIMM17B, and BHLHE40 exhibits the highest cell-type specificity in IgA plasma cells for potential targeting in Sjögren syndrome?","Which gene among PODXL, MIF, KMT2D, TIMM17B, and BHLHE40 exhibits the highest cell-type specificity in IgA plasma cells for potential targeting in Sjögren syndrome? Identify the cell-type–specific embeddings from PINNACLE for the verified therapeutic targets of Sjögren syndrome. Then, determine which of these targets overlap with the IgA plasma cell-activated genes in PINNACLE. Calculate the average embedding of this overlapping gene set as a reference and compute the cosine similarity between this reference and each individual target’s embedding. If one gene exhibits a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PSORS1C2', 'ARNTL2', 'DCAF15', 'DYNLT5', 'HLA-B']",Sjogren syndrome,iga plasma cell,HLA-B,"Which gene among PSORS1C2, ARNTL2, DCAF15, DYNLT5, and HLA-B exhibits the highest cell-type specificity in IgA plasma cells for targeting Sjögren's syndrome?","Which gene among PSORS1C2, ARNTL2, DCAF15, DYNLT5, and HLA-B exhibits the highest cell-type specificity in IgA plasma cells for targeting Sjögren's syndrome? Identify the verified therapeutic targets for Sjögren syndrome and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which genes, activated in IgA plasma cells in PINNACLE, overlap with these therapeutic targets. This overlapping set represents the cell-type–specific targets for Sjögren syndrome. Compute the average embedding for this set as a reference, and then calculate the cosine similarity between the reference and each individual gene embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PHOX2A', 'PFKM', 'TNFAIP3', 'ATP6V1H', 'MANF']",Sjogren syndrome,iga plasma cell,TNFAIP3,"Which gene among PHOX2A, PFKM, TNFAIP3, ATP6V1H, and MANF exhibits the most selective expression in IgA plasma cells for potential targeting in Sjögren syndrome?","Which gene among PHOX2A, PFKM, TNFAIP3, ATP6V1H, and MANF exhibits the most selective expression in IgA plasma cells for potential targeting in Sjögren syndrome? Identify validated therapeutic targets for Sjogren syndrome and extract their cell‐type–specific embeddings from PINNACLE. Then, determine which of these targets overlap with the iga plasma cell–activated genes from PINNACLE. Compute the average embedding of the overlapping genes as a reference, and calculate the cosine similarity between this reference embedding and each individual target. If one gene shows significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PHLDA3', 'CTSS', 'GYPB', 'DLX5', 'CEBPD']",Sjogren syndrome,iga plasma cell,CTSS,"Among the genes PHLDA3, CTSS, GYPB, DLX5, and CEBPD, which one shows the highest expression specificity in IgA plasma cells, thereby representing the most promising target for Sjögren syndrome?","Among the genes PHLDA3, CTSS, GYPB, DLX5, and CEBPD, which one shows the highest expression specificity in IgA plasma cells, thereby representing the most promising target for Sjögren syndrome? Identify the verified therapeutic targets for Sjogren syndrome and retrieve their cell-type–specific embeddings from PINNACLE. Then, determine the overlap between these targets and the genes activated in IGA plasma cells from PINNACLE, thus defining the cell-specific targets for Sjogren syndrome. Compute the average embedding of these overlapping targets as a reference, and calculate the cosine similarity between this reference and each individual target. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CD300LB', 'SCAMP3', 'ITLN1', 'NOLC1', 'PPIA']",Sjogren syndrome,iga plasma cell,PPIA,"Among the genes CD300LB, SCAMP3, ITLN1, NOLC1, and PPIA, which exhibits the highest cell-type specificity in IgA plasma cells relevant to targeting Sjögren syndrome?","Among the genes CD300LB, SCAMP3, ITLN1, NOLC1, and PPIA, which exhibits the highest cell-type specificity in IgA plasma cells relevant to targeting Sjögren syndrome? Identify the verified therapeutic targets for Sjögren syndrome and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine the overlap between these targets and IgA plasma cell-activated genes from PINNACLE, and compute an average embedding as a reference vector for the overlapping set. Calculate the cosine similarity between this reference and each individual target gene. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['TMEM129', 'SLCO1B3', 'COL12A1', 'RNGTT', 'HLA-DPA1']",Sjogren syndrome,endothelial cell,HLA-DPA1,"Among TMEM129, SLCO1B3, COL12A1, RNGTT, and HLA-DPA1, which gene exhibits the most endothelial cell-specific expression, making it the most promising candidate target for therapeutic intervention in Sjögren syndrome?","Among TMEM129, SLCO1B3, COL12A1, RNGTT, and HLA-DPA1, which gene exhibits the most endothelial cell-specific expression, making it the most promising candidate target for therapeutic intervention in Sjögren syndrome? Using validated therapeutic targets for Sjögren syndrome, extract their cell-type–specific embeddings from PINNACLE. Identify the overlap between these targets and endothelial cell-activated genes in PINNACLE, and compute the average embedding for this intersecting set as a reference. Then, calculate the cosine similarity between each individual target's embedding and the reference embedding. If one gene demonstrates a markedly higher similarity compared to the others, nominate it as the top candidate and provide a brief, evidence-based rationale for its biological significance."
"['DDX6', 'STT3B', 'PRRG1', 'MTMR2', 'PGRMC2']",Sjogren syndrome,endothelial cell,DDX6,"Which gene among DDX6, STT3B, PRRG1, MTMR2, and PGRMC2 exhibits the highest endothelial cell-specific expression, making it the most promising candidate for targeted interventions in Sjögren syndrome?","Which gene among DDX6, STT3B, PRRG1, MTMR2, and PGRMC2 exhibits the highest endothelial cell-specific expression, making it the most promising candidate for targeted interventions in Sjögren syndrome? Identify the validated therapeutic targets for Sjögren syndrome and obtain their cell-type-specific embeddings from PINNACLE. Next, determine which of these targets overlap with genes activated in endothelial cells. For the overlapping set, compute the average embedding and then calculate the cosine similarity between each gene’s embedding and this average. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate, providing a concise, evidence-based explanation for its biological relevance."
"['TBC1D10A', 'BAZ2A', 'KLF4', 'P4HTM', 'TDP2']",Sjogren syndrome,endothelial cell,BAZ2A,"Among the genes TBC1D10A, BAZ2A, KLF4, P4HTM, and TDP2, which one shows the most specific expression in endothelial cells and could serve as a potential therapeutic target for Sjögren syndrome?","Among the genes TBC1D10A, BAZ2A, KLF4, P4HTM, and TDP2, which one shows the most specific expression in endothelial cells and could serve as a potential therapeutic target for Sjögren syndrome? Identify the validated therapeutic targets for Sjögren syndrome and extract their corresponding cell-type–specific embeddings from the PINNACLE dataset. Next, find the overlap between these targets and the endothelial cell-activated genes in PINNACLE, and compute the average embedding of this overlapping set as a reference. Then, calculate the cosine similarity between this reference and each individual gene in the set. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SCTR', 'GDF10', 'PRPH', 'JAK1', 'RABL2B']",Sjogren syndrome,endothelial cell,JAK1,"Which gene among SCTR, GDF10, PRPH, JAK1, and RABL2B exhibits the greatest endothelial cell-specific expression, making it the most promising candidate for therapeutic targeting in Sjogren syndrome?","Which gene among SCTR, GDF10, PRPH, JAK1, and RABL2B exhibits the greatest endothelial cell-specific expression, making it the most promising candidate for therapeutic targeting in Sjogren syndrome? Identify the established therapeutic targets for Sjogren syndrome and extract their cell-type–specific embeddings from PINNACLE. Next, determine which endothelial cell-activated genes in PINNACLE overlap with these targets to define the cell-type–specific targets for Sjogren syndrome. Calculate the average embedding of this overlapping set as a reference and then compute the cosine similarity between this reference and each individual target's embedding. If one gene displays a notably higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological significance."
"['DOLPP1', 'C1orf21', 'NR3C1', 'TRIM32', 'XDH']",Sjogren syndrome,endothelial cell,NR3C1,"Which gene among DOLPP1, C1orf21, NR3C1, TRIM32, and XDH exhibits the highest specificity of expression in endothelial cells, making it the most promising target for therapeutic intervention in Sjögren's syndrome?","Which gene among DOLPP1, C1orf21, NR3C1, TRIM32, and XDH exhibits the highest specificity of expression in endothelial cells, making it the most promising target for therapeutic intervention in Sjögren's syndrome? Identify the experimentally validated therapeutic targets for Sjogren syndrome and obtain their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the endothelial cell–activated genes in PINNACLE to define the cell-type–specific gene set for Sjogren syndrome. Compute the average embedding for these overlapping genes and calculate the cosine similarity between this reference and each individual target. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['NCR3LG1', 'RBMX', 'LMX1B', 'PPIA', 'PAM']",Sjogren syndrome,endothelial cell,PPIA,"Which gene among NCR3LG1, RBMX, LMX1B, PPIA, and PAM exhibits the highest specificity for endothelial cells in the context of targeting Sjogren syndrome?","Which gene among NCR3LG1, RBMX, LMX1B, PPIA, and PAM exhibits the highest specificity for endothelial cells in the context of targeting Sjogren syndrome? Determine the verified therapeutic targets for Sjogren syndrome and extract their cell-type–specific embeddings from PINNACLE. Identify the subset of these targets that overlaps with endothelial cell-activation genes, and compute the average embedding for this overlapping set as a reference. Next, calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate, providing a concise, evidence-based rationale for its biological relevance."
"['ZDHHC11', 'FDXACB1', 'WWOX', 'GTF2I', 'DAPP1']",Sjogren syndrome,endothelial cell,GTF2I,"Among the candidate genes ZDHHC11, FDXACB1, WWOX, GTF2I, and DAPP1, which one exhibits the highest endothelial cell specificity as a potential target for Sjögren syndrome?","Among the candidate genes ZDHHC11, FDXACB1, WWOX, GTF2I, and DAPP1, which one exhibits the highest endothelial cell specificity as a potential target for Sjögren syndrome? Identify experimentally validated therapeutic targets for Sjogren syndrome and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which targets overlap with the endothelial cell-activated genes in PINNACLE, and compute the average embedding for these overlapping targets. Finally, calculate the cosine similarity between this average embedding and each individual target embedding; if one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['DHX32', 'RCN1', 'COX7C', 'DDX55', 'RBM11']",Sjogren syndrome,endothelial cell,RCN1,"Among the candidate genes DHX32, RCN1, COX7C, DDX55, and RBM11, which one exhibits the highest endothelial cell–specific expression relevant to targeting Sjogren syndrome?","Among the candidate genes DHX32, RCN1, COX7C, DDX55, and RBM11, which one exhibits the highest endothelial cell–specific expression relevant to targeting Sjogren syndrome? Identify the validated therapeutic targets for Sjogren syndrome and obtain their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which of these targets overlap with the endothelial cell-activated genes in PINNACLE, and calculate the average embedding for this overlapping set. Then compute the cosine similarity between this average embedding and each individual target. If one gene shows a significantly higher similarity than the others, nominate that gene as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['ZNF774', 'IFNAR1', 'PPM1K', 'RAB5B', 'KITLG']",Sjogren syndrome,endothelial cell,IFNAR1,"Among the genes ZNF774, IFNAR1, PPM1K, RAB5B, and KITLG, which demonstrates the highest specificity to endothelial cells in the context of targeting Sjogren syndrome?","Among the genes ZNF774, IFNAR1, PPM1K, RAB5B, and KITLG, which demonstrates the highest specificity to endothelial cells in the context of targeting Sjogren syndrome? Using the confirmed therapeutic targets for Sjögren syndrome, retrieve their cell-type–specific embeddings from the PINNACLE dataset. Next, identify which of these targets overlap with endothelial cell-activated genes to define a set of cell-type–specific targets for the syndrome. Calculate the average embedding of this set and then determine the cosine similarity between this reference and each individual target. If one gene exhibits a noticeably higher similarity, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['KRT75', 'PUF60', 'KCND1', 'PGPEP1', 'GTF2I']",Sjogren syndrome,endothelial cell,GTF2I,"Which gene among KRT75, PUF60, KCND1, PGPEP1, and GTF2I demonstrates the highest endothelial cell-specific expression relevant to targeting Sjogren syndrome?","Which gene among KRT75, PUF60, KCND1, PGPEP1, and GTF2I demonstrates the highest endothelial cell-specific expression relevant to targeting Sjogren syndrome? Identify all verified therapeutic targets for Sjogren syndrome and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine the intersection between these targets and the endothelial cell–activated genes from PINNACLE. For the overlapping set, compute the average embedding and calculate the cosine similarity between this reference and the embedding of each individual target. If one gene exhibits a substantially higher similarity than the others, nominate it as the top candidate and provide a succinct, evidence-based explanation for its biological relevance."
"['CD36', 'MSI2', 'SYT9', 'RCN1', 'DUT']",Sjogren syndrome,endothelial cell,RCN1,"Among the genes CD36, MSI2, SYT9, RCN1, and DUT, which one demonstrates the highest cell-type specificity in endothelial cells for potential therapeutic targeting of Sjögren's syndrome?","Among the genes CD36, MSI2, SYT9, RCN1, and DUT, which one demonstrates the highest cell-type specificity in endothelial cells for potential therapeutic targeting of Sjögren's syndrome? Identify the validated therapeutic targets for Sjogren syndrome and obtain their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the endothelial cell-activated genes defined in PINNACLE. Compute the average embedding of the overlapping genes to serve as a reference, and then calculate the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than all others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TRHDE', 'KHDRBS1', 'IFNAR1', 'RAC2', 'IFITM2']",Sjogren syndrome,endothelial cell,IFNAR1,"Among the following genes—TRHDE, KHDRBS1, IFNAR1, RAC2, and IFITM2—which exhibits the greatest specificity for endothelial cells, thereby representing the most promising single target for addressing Sjogren’s syndrome?","Among the following genes—TRHDE, KHDRBS1, IFNAR1, RAC2, and IFITM2—which exhibits the greatest specificity for endothelial cells, thereby representing the most promising single target for addressing Sjogren’s syndrome? Identify the validated therapeutic targets for Sjogren syndrome and extract their cell-type–specific embeddings from PINNACLE. Next, determine which endothelial cell-activated genes in PINNACLE overlap with these targets. Compute the average embedding of this overlapping set and then calculate the cosine similarity between this reference and each individual target gene. If one gene exhibits a significantly higher similarity than all others, nominate it as the top candidate, and provide a concise, evidence-based explanation for its biological relevance."
"['PTPRM', 'ADCY6', 'CDC73', 'BLID', 'JAK1']",Sjogren syndrome,endothelial cell,JAK1,"Which gene among PTPRM, ADCY6, CDC73, BLID, and JAK1 exhibits the highest endothelial cell-specific expression, thereby representing the most suitable candidate for targeted intervention in Sjogren syndrome?","Which gene among PTPRM, ADCY6, CDC73, BLID, and JAK1 exhibits the highest endothelial cell-specific expression, thereby representing the most suitable candidate for targeted intervention in Sjogren syndrome? Identify the validated therapeutic targets for Sjögren syndrome and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the endothelial cell-activated genes in PINNACLE; this overlapping set represents the cell-type–specific targets for Sjögren syndrome. Calculate the average embedding of this set as a reference, then compute the cosine similarity between this reference and the embedding of each individual target gene. If one gene exhibits a substantially higher similarity than the others, nominate this gene as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['LEP', 'LBR', 'RAMP3', 'MAB21L3', 'HLA-DPA1']",Sjogren syndrome,endothelial cell,HLA-DPA1,"Among the genes LEP, LBR, RAMP3, MAB21L3, and HLA-DPA1, which one shows the highest specificity for endothelial cells and is thus the optimal candidate for targeted intervention in Sjögren’s syndrome?","Among the genes LEP, LBR, RAMP3, MAB21L3, and HLA-DPA1, which one shows the highest specificity for endothelial cells and is thus the optimal candidate for targeted intervention in Sjögren’s syndrome? Identify verified therapeutic targets for Sjögren's syndrome and extract their cell-type specific embeddings from PINNACLE. Next, identify which of the endothelial cell-activated genes in PINNACLE overlap with these targets to define the cell-type specific therapeutic set. Calculate the average embedding of this overlapping set as a reference, then determine the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher similarity, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PLAUR', 'MMP28', 'TIFA', 'DDX6', 'PRMT7']",Sjogren syndrome,endothelial cell,DDX6,"Among the genes PLAUR, MMP28, TIFA, DDX6, and PRMT7, which one shows the highest specificity of expression in endothelial cells, making it the most promising candidate for targeting Sjögren's syndrome?","Among the genes PLAUR, MMP28, TIFA, DDX6, and PRMT7, which one shows the highest specificity of expression in endothelial cells, making it the most promising candidate for targeting Sjögren's syndrome? Identify the validated therapeutic targets for Sjögren syndrome and retrieve their cell-type–specific embeddings from PINNACLE. Then, determine which of these targets overlap with the endothelial cell–activated genes in PINNACLE. For the overlapping set, calculate the average embedding and compute the cosine similarity between this average and each individual target’s embedding. If one gene shows a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PPIA', 'COPS9', 'TIMELESS', 'STXBP5L', 'NFKB2']",Sjogren syndrome,endothelial cell,PPIA,"Among the genes PPIA, COPS9, TIMELESS, STXBP5L, and NFKB2, which one demonstrates the highest endothelial cell specificity relevant for targeting Sjögren syndrome?","Among the genes PPIA, COPS9, TIMELESS, STXBP5L, and NFKB2, which one demonstrates the highest endothelial cell specificity relevant for targeting Sjögren syndrome? Identify validated therapeutic targets for Sjögren's syndrome and obtain their cell-type–specific embeddings from PINNACLE. Next, extract the embeddings of genes activated in endothelial cells from PINNACLE and determine the overlap with the therapeutic targets, defining these as the cell-type–specific targets. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between this reference and each individual target gene. If one gene exhibits a significantly higher similarity compared to the others, nominate it as the top candidate, providing a clear, evidence-based rationale for its potential biological relevance in Sjögren's syndrome."
"['SETD3', 'ACVRL1', 'GHSR', 'NR3C1', 'PRELID3A']",Sjogren syndrome,endothelial cell,NR3C1,"Among the genes SETD3, ACVRL1, GHSR, NR3C1, and PRELID3A, which one exhibits the most specific expression in endothelial cells, making it the most promising target for therapeutic intervention in Sjogren syndrome?","Among the genes SETD3, ACVRL1, GHSR, NR3C1, and PRELID3A, which one exhibits the most specific expression in endothelial cells, making it the most promising target for therapeutic intervention in Sjogren syndrome? Identify verified therapeutic targets for Sjogren syndrome and extract their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the endothelial cell-activated genes in PINNACLE, and compute the average embedding of this overlapping set as a reference. Then, calculate the cosine similarity between the reference and each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['C18orf25', 'BAZ2A', 'DIO3', 'PDLIM1', 'BAG6']",Sjogren syndrome,endothelial cell,BAZ2A,"Which gene among C18orf25, BAZ2A, DIO3, PDLIM1, and BAG6 exhibits the greatest endothelial cell-specific expression, making it the most promising candidate for targeting Sjögren's syndrome?","Which gene among C18orf25, BAZ2A, DIO3, PDLIM1, and BAG6 exhibits the greatest endothelial cell-specific expression, making it the most promising candidate for targeting Sjögren's syndrome? Identify the validated therapeutic targets for Sjogren syndrome and obtain their cell-type-specific embeddings from PINNACLE. Next, determine which of the endothelial cell-activated genes in PINNACLE overlap with these targets. Compute the average embedding for this overlapping set and then calculate the cosine similarity between this average and each individual gene's embedding. If one gene shows significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TRIM4', 'HLA-DPA1', 'SCGB2B2', 'RASL10B', 'AVPI1']",Sjogren syndrome,endothelial cell,HLA-DPA1,"Among TRIM4, HLA-DPA1, SCGB2B2, RASL10B, and AVPI1, which gene exhibits the highest endothelial cell-type specificity, making it the most promising candidate for targeting in Sjogren syndrome?","Among TRIM4, HLA-DPA1, SCGB2B2, RASL10B, and AVPI1, which gene exhibits the highest endothelial cell-type specificity, making it the most promising candidate for targeting in Sjogren syndrome? Identify the verified therapeutic targets for Sjogren syndrome and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine which of the endothelial cell–activated genes in PINNACLE overlap with these targets. For the overlapping set, compute the average embedding and calculate the cosine similarity between this average and each individual target's embedding. If one gene exhibits a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PPP1R2C', 'JAK1', 'TEX33', 'MCM3', 'ATP5IF1']",Sjogren syndrome,endothelial cell,JAK1,"Which gene among PPP1R2C, JAK1, TEX33, MCM3, and ATP5IF1 exhibits the highest specificity for endothelial cells, making it the most suitable candidate for targeted interventions in Sjögren's syndrome?","Which gene among PPP1R2C, JAK1, TEX33, MCM3, and ATP5IF1 exhibits the highest specificity for endothelial cells, making it the most suitable candidate for targeted interventions in Sjögren's syndrome? Identify confirmed therapeutic targets for Sjögren's syndrome and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with endothelial cell–activated genes in PINNACLE. Calculate the average embedding for this overlapping set to serve as a reference, and then assess the cosine similarity between this reference and each individual target’s embedding. If one gene demonstrates a markedly higher similarity compared to the others, designate it as the top candidate and provide a brief, evidence-based explanation for its biological significance."
"['C20orf85', 'CDK10', 'UBE2R2', 'FDCSP', 'FCGRT']",Sjogren syndrome,duct epithelial cell,FCGRT,"Which gene among C20orf85, CDK10, UBE2R2, FDCSP, and FCGRT exhibits the highest specificity for duct epithelial cells in the context of targeting Sjögren's syndrome?","Which gene among C20orf85, CDK10, UBE2R2, FDCSP, and FCGRT exhibits the highest specificity for duct epithelial cells in the context of targeting Sjögren's syndrome? Identify the verified therapeutic targets for Sjögren syndrome and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which duct epithelial cell‐activated genes in PINNACLE overlap with these targets to define the disease‐relevant, cell‐type–specific gene set. Calculate the average embedding of this overlapping set as a reference, and then compute the cosine similarity between this reference and each individual target gene. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['B9D1', 'ACKR4', 'EPOR', 'PPIA', 'PKN2']",Sjogren syndrome,duct epithelial cell,PPIA,"Which gene among B9D1, ACKR4, EPOR, PPIA, and PKN2 exhibits the highest cell-type specificity in duct epithelial cells as a target for Sjögren's syndrome?","Which gene among B9D1, ACKR4, EPOR, PPIA, and PKN2 exhibits the highest cell-type specificity in duct epithelial cells as a target for Sjögren's syndrome? Identify validated therapeutic targets for Sjögren's syndrome and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with duct epithelial cell-activated genes from PINNACLE. Compute the average embedding for the overlapping set and calculate the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate, providing a concise, evidence-based explanation for its biological relevance."
"['DAGLA', 'HLA-DRA', 'MXD4', 'ATXN1L', 'SPSB3']",Sjogren syndrome,duct epithelial cell,HLA-DRA,"Which gene—DAGLA, HLA-DRA, MXD4, ATXN1L, or SPSB3—exhibits the most specific expression in ductal epithelial cells relevant for targeting Sjögren syndrome?","Which gene—DAGLA, HLA-DRA, MXD4, ATXN1L, or SPSB3—exhibits the most specific expression in ductal epithelial cells relevant for targeting Sjögren syndrome? Identify the verified therapeutic targets for Sjogren syndrome and obtain their cell-type specific embeddings from PINNACLE. Next, determine which of the activated duct epithelial cell genes in PINNACLE overlap with these targets. For this overlapping set, calculate the average embedding and then compute the cosine similarity between this average and each individual gene embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['GGT6', 'TRPC3', 'HLA-DPB1', 'MBTD1', 'CSNK2A2']",Sjogren syndrome,duct epithelial cell,HLA-DPB1,"Which gene among GGT6, TRPC3, HLA-DPB1, MBTD1, and CSNK2A2 shows the highest specificity for duct epithelial cells, making it the most promising target for Sjögren's syndrome intervention?","Which gene among GGT6, TRPC3, HLA-DPB1, MBTD1, and CSNK2A2 shows the highest specificity for duct epithelial cells, making it the most promising target for Sjögren's syndrome intervention? Identify the validated therapeutic targets for Sjögren's syndrome and obtain their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which of these targets overlap with the duct epithelial cell-activated genes in PINNACLE, defining the cell-type–specific targets. Calculate the average embedding for this overlapping set, then compute the cosine similarity between this reference and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['H3C10', 'HLA-B', 'KMT2C', 'CNN2', 'DGAT2L6']",Sjogren syndrome,duct epithelial cell,HLA-B,"Among the genes H3C10, HLA-B, KMT2C, CNN2, and DGAT2L6, which one exhibits the highest cell-type-specific expression in duct epithelial cells relevant to Sjögren syndrome?","Among the genes H3C10, HLA-B, KMT2C, CNN2, and DGAT2L6, which one exhibits the highest cell-type-specific expression in duct epithelial cells relevant to Sjögren syndrome? Identify the validated therapeutic targets for Sjogren syndrome and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the duct epithelial cell‐activated gene set from PINNACLE, defining your cell-type–specific targets. Calculate the average embedding for this overlapping set and compute the cosine similarity between this average and each individual target’s embedding. If one gene shows substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MAPK8IP3', 'TRIM69', 'PLEKHF2', 'EYA1', 'IMPDH2']",Sjogren syndrome,duct epithelial cell,IMPDH2,"Which gene among MAPK8IP3, TRIM69, PLEKHF2, EYA1, and IMPDH2 exhibits the most specific expression in ductal epithelial cells, making it the most promising candidate for targeted interventions in Sjögren syndrome?","Which gene among MAPK8IP3, TRIM69, PLEKHF2, EYA1, and IMPDH2 exhibits the most specific expression in ductal epithelial cells, making it the most promising candidate for targeted interventions in Sjögren syndrome? Identify the verified therapeutic targets for Sjögren syndrome and obtain their cell-type-specific embeddings from PINNACLE. Next, determine which duct epithelial cell-activated genes in PINNACLE overlap with these targets. For the overlapping set, compute the average embedding and then calculate the cosine similarity between this reference embedding and each individual gene embedding. If one gene shows a markedly higher cosine similarity than the others, nominate it as the top candidate and provide a concise, evidence-based justification for its biological relevance."
"['IMPDH2', 'NLRC4', 'RPL23AP32', 'ITGB3', 'ECD']",Sjogren syndrome,duct epithelial cell,IMPDH2,"Among IMPDH2, NLRC4, RPL23AP32, ITGB3, and ECD, which gene exhibits the highest cell-type specificity in duct epithelial cells relevant to Sjögren syndrome?","Among IMPDH2, NLRC4, RPL23AP32, ITGB3, and ECD, which gene exhibits the highest cell-type specificity in duct epithelial cells relevant to Sjögren syndrome? Identify the cell-type–specific embeddings in PINNACLE for the verified therapeutic targets of Sjogren’s syndrome, and determine the overlap with genes activated in duct epithelial cells. For these overlapping targets, compute the average embedding as a reference and then calculate the cosine similarity between this average and each individual target’s embedding. If one gene shows a notably higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['PWWP2B', 'IGFALS', 'FZD4', 'HLA-DRA', 'GALNT14']",Sjogren syndrome,duct epithelial cell,HLA-DRA,"Which gene among PWWP2B, IGFALS, FZD4, HLA-DRA, and GALNT14 exhibits the highest specificity for ductal epithelial cells, thereby representing the best candidate for targeted intervention in Sjogren syndrome?","Which gene among PWWP2B, IGFALS, FZD4, HLA-DRA, and GALNT14 exhibits the highest specificity for ductal epithelial cells, thereby representing the best candidate for targeted intervention in Sjogren syndrome? Identify verified therapeutic targets for Sjogren syndrome and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which targets overlap with duct epithelial cell–activated genes in PINNACLE, and compute an average embedding for this overlapping set. Finally, calculate the cosine similarity between this reference embedding and each individual target’s embedding. If one gene shows a significantly higher similarity than the others, designate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['UVSSA', 'HLA-DPB1', 'AGO4', 'CMTM3', 'BAHD1']",Sjogren syndrome,duct epithelial cell,HLA-DPB1,"Among UVSSA, HLA-DPB1, AGO4, CMTM3, and BAHD1, which gene exhibits the highest cell-type specificity in duct epithelial cells in the context of Sjögren syndrome targeting?","Among UVSSA, HLA-DPB1, AGO4, CMTM3, and BAHD1, which gene exhibits the highest cell-type specificity in duct epithelial cells in the context of Sjögren syndrome targeting? Identify the verified therapeutic targets for Sjogren syndrome and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the genes activated in duct epithelial cells in PINNACLE to create a set of cell-type–specific targets. Compute the average embedding for this overlapping set and calculate the cosine similarity between this average and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PPIA', 'CLTCL1', 'NOL12', 'HSPA4L', 'RLN2']",Sjogren syndrome,duct epithelial cell,PPIA,"Which gene among PPIA, CLTCL1, NOL12, HSPA4L, and RLN2 exhibits the highest cell-type specificity in ductal epithelial cells for targeting Sjögren syndrome?","Which gene among PPIA, CLTCL1, NOL12, HSPA4L, and RLN2 exhibits the highest cell-type specificity in ductal epithelial cells for targeting Sjögren syndrome? Identify the validated therapeutic targets for Sjogren syndrome and extract their cell-type-specific PINNACLE embeddings. From these targets, determine the subset that overlaps with duct epithelial cell-activated genes, and compute the average embedding of this overlapping set. Next, calculate the cosine similarity between this average embedding and each individual target’s embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance in Sjogren syndrome."
"['ABCB4', 'USO1', 'FCGRT', 'PLAAT5', 'LUC7L2']",Sjogren syndrome,duct epithelial cell,FCGRT,"Among the genes ABCB4, USO1, FCGRT, PLAAT5, and LUC7L2, which exhibits the highest cell-type specificity in duct epithelial cells for applications in Sjögren syndrome research?","Among the genes ABCB4, USO1, FCGRT, PLAAT5, and LUC7L2, which exhibits the highest cell-type specificity in duct epithelial cells for applications in Sjögren syndrome research? Identify the validated therapeutic targets for Sjögren syndrome and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine the intersection between these targets and the duct epithelial cell-activated genes in PINNACLE. Compute the average embedding of this intersecting gene set and calculate the cosine similarity between this average embedding and each individual target's embedding. If a single gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['AAMDC', 'HLA-B', 'RNU2-1', 'PRPS1L1', 'TTR']",Sjogren syndrome,duct epithelial cell,HLA-B,"Among the genes AAMDC, HLA-B, RNU2-1, PRPS1L1, and TTR, which one exhibits the highest cell-type specificity in ductal epithelial cells, making it the most promising candidate for targeted intervention in Sjögren’s syndrome?","Among the genes AAMDC, HLA-B, RNU2-1, PRPS1L1, and TTR, which one exhibits the highest cell-type specificity in ductal epithelial cells, making it the most promising candidate for targeted intervention in Sjögren’s syndrome? Identify the validated therapeutic targets for Sjogren syndrome and retrieve their cell-type-specific embeddings from PINNACLE. Next, determine the overlap between these targets and the duct epithelial cell-activated genes in PINNACLE to define the cell-type-specific targets for Sjogren syndrome. Calculate the average embedding for this overlapping set and then assess the cosine similarity between this reference embedding and each individual gene embedding. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['FXN', 'RPL36', 'ZNF71', 'HLA-B', 'YTHDF1']",Sjogren syndrome,duct epithelial cell,HLA-B,"Among the genes FXN, RPL36, ZNF71, HLA-B, and YTHDF1, which one exhibits the highest cell-type-specific expression in duct epithelial cells and therefore represents the most promising target for interventions in Sjögren’s syndrome?","Among the genes FXN, RPL36, ZNF71, HLA-B, and YTHDF1, which one exhibits the highest cell-type-specific expression in duct epithelial cells and therefore represents the most promising target for interventions in Sjögren’s syndrome? Which verified therapeutic targets for Sjogren syndrome, with their cell-type–specific embeddings from PINNACLE, overlap with the duct epithelial cell-activated genes in the same dataset? For this overlapping set of targets, calculate the average embedding as a reference and then assess the cosine similarity between this reference and each individual gene’s embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based explanation detailing its biological relevance."
"['GCG', 'HLA-DRA', 'GFRA2', 'TXNDC15', 'SMIM11B']",Sjogren syndrome,duct epithelial cell,HLA-DRA,"Which gene among GCG, HLA-DRA, GFRA2, TXNDC15, and SMIM11B exhibits the highest cell-type specificity in duct epithelial cells for potential targeted therapy in Sjögren's syndrome?","Which gene among GCG, HLA-DRA, GFRA2, TXNDC15, and SMIM11B exhibits the highest cell-type specificity in duct epithelial cells for potential targeted therapy in Sjögren's syndrome? Identify validated therapeutic targets for primary Sjögren syndrome and obtain their corresponding cell-type-specific embeddings from the PINNACLE dataset. Next, identify which of the duct epithelial cell–activated genes in PINNACLE overlap with these targets. For the overlapping set, compute the average embedding and calculate the cosine similarity between this average and the embedding of each individual gene. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ASIP', 'SUPT7L', 'PPIA', 'FAM153A', 'RAPGEF3']",Sjogren syndrome,duct epithelial cell,PPIA,"Which gene among ASIP, SUPT7L, PPIA, FAM153A, and RAPGEF3 exhibits the highest cell-type specificity in duct epithelial cells, making it the most promising candidate for targeting Sjögren syndrome?","Which gene among ASIP, SUPT7L, PPIA, FAM153A, and RAPGEF3 exhibits the highest cell-type specificity in duct epithelial cells, making it the most promising candidate for targeting Sjögren syndrome? Identify the validated therapeutic targets for Sjögren syndrome and obtain their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the duct epithelial cell-activated genes in PINNACLE to define the cell-type–specific targets for Sjögren syndrome. Compute the average embedding for this overlapping set to serve as a reference, then calculate the cosine similarity between this reference and each individual target. If one gene demonstrates a markedly higher similarity than the others, nominate it as the primary candidate and provide a concise, evidence-based rationale for its biological relevance."
"['HLA-DPB1', 'IRX6', 'DHRS11', 'ALPP', 'PTPRK']",Sjogren syndrome,duct epithelial cell,HLA-DPB1,"Among HLA-DPB1, IRX6, DHRS11, ALPP, and PTPRK, which gene exhibits the highest cell-type specificity in duct epithelial cells and represents the best candidate for targeting in Sjogren syndrome?","Among HLA-DPB1, IRX6, DHRS11, ALPP, and PTPRK, which gene exhibits the highest cell-type specificity in duct epithelial cells and represents the best candidate for targeting in Sjogren syndrome? Identify and extract validated therapeutic targets for Sjogren syndrome, then obtain their cell-type–specific embeddings from PINNACLE. Next, determine which duct epithelial cell-activated genes in PINNACLE overlap these targets to form a refined list of cell-type–specific therapeutic targets. Calculate the average embedding of this set as a reference and compute the cosine similarity between this reference and each individual target’s embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ENPP7', 'SPRYD3', 'CD59', 'ACOX1', 'FCGRT']",Sjogren syndrome,duct epithelial cell,FCGRT,"Which gene—ENPP7, SPRYD3, CD59, ACOX1, or FCGRT—displays the highest cell-type specific expression in ductal epithelial cells, making it the best candidate for targeted intervention in Sjögren’s syndrome?","Which gene—ENPP7, SPRYD3, CD59, ACOX1, or FCGRT—displays the highest cell-type specific expression in ductal epithelial cells, making it the best candidate for targeted intervention in Sjögren’s syndrome? Identify the verified therapeutic targets for Sjogren syndrome and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with duct epithelial cell-activated genes in PINNACLE. For the overlapping genes, compute the average embedding as a reference and calculate the cosine similarity between this reference and each individual gene embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the leading candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SH3PXD2A', 'IMPDH2', 'S1PR3', 'CSDC2', 'ARL6IP5']",Sjogren syndrome,duct epithelial cell,IMPDH2,"Which gene among SH3PXD2A, IMPDH2, S1PR3, CSDC2, and ARL6IP5 exhibits the highest cell-type specificity in duct epithelial cells for targeting Sjögren's syndrome?","Which gene among SH3PXD2A, IMPDH2, S1PR3, CSDC2, and ARL6IP5 exhibits the highest cell-type specificity in duct epithelial cells for targeting Sjögren's syndrome? Identify the validated therapeutic targets for Sjögren syndrome and extract their corresponding cell-type–specific embeddings from the PINNACLE database. Next, determine which of the genes activated in duct epithelial cells overlap with these therapeutic targets. Compute the average embedding from this overlapping set as a reference and calculate the cosine similarity between this reference and each individual gene’s embedding. If a single gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['IMPDH2', 'TGM7', 'H2AC14', 'DCAF16', 'KRI1']",Sjogren syndrome,duct epithelial cell,IMPDH2,"Which gene among IMPDH2, TGM7, H2AC14, DCAF16, and KRI1 exhibits the highest specificity for duct epithelial cells in the context of targeting Sjogren syndrome?","Which gene among IMPDH2, TGM7, H2AC14, DCAF16, and KRI1 exhibits the highest specificity for duct epithelial cells in the context of targeting Sjogren syndrome? Identify verified therapeutic targets for Sjogren syndrome and extract their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and duct epithelial cell–activated genes in PINNACLE to define a set of cell-type–specific targets. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate, and provide a concise, evidence-based explanation for its biological relevance."
"['HLA-B', 'SLC38A3', 'SOX1', 'AKAP9', 'UBXN10']",Sjogren syndrome,duct epithelial cell,HLA-B,"Which gene among HLA-B, SLC38A3, SOX1, AKAP9, and UBXN10 demonstrates the highest cell-type specificity in duct epithelial cells for targeting Sjögren syndrome?","Which gene among HLA-B, SLC38A3, SOX1, AKAP9, and UBXN10 demonstrates the highest cell-type specificity in duct epithelial cells for targeting Sjögren syndrome? Identify the verified therapeutic targets for Sjogren syndrome and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the genes activated in duct epithelial cells within PINNACLE. Calculate the average embedding of this overlapping set, then compute the cosine similarity between the average and each individual gene embedding. Identify the gene with the highest cosine similarity as the prime candidate and provide a concise, evidence-based rationale for its biological relevance."
"['GIMAP1', 'HLA-B', 'DVL1P1', 'FLOT1', 'GZMB']",Sjogren syndrome,myoepithelial cell,HLA-B,"Which gene among GIMAP1, HLA-B, DVL1P1, FLOT1, and GZMB exhibits the highest cell-type specificity in myoepithelial cells, making it the most promising candidate for targeting Sjögren syndrome?","Which gene among GIMAP1, HLA-B, DVL1P1, FLOT1, and GZMB exhibits the highest cell-type specificity in myoepithelial cells, making it the most promising candidate for targeting Sjögren syndrome? Using verified therapeutic targets for Sjogren syndrome, extract their cell-type–specific embeddings from PINNACLE. Next, identify which myoepithelial cell-activated genes in PINNACLE overlap with these targets. Calculate the average embedding of this overlapping set to serve as a reference, and compute the cosine similarity between this reference and each individual target. If one gene displays significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['CBLN1', 'NAT8B', 'ZBTB38', 'PPIA', 'TMEM38B']",Sjogren syndrome,myoepithelial cell,PPIA,"Which gene among CBLN1, NAT8B, ZBTB38, PPIA, and TMEM38B exhibits the highest cell-type specificity in myoepithelial cells, making it a promising target for Sjogren syndrome research?","Which gene among CBLN1, NAT8B, ZBTB38, PPIA, and TMEM38B exhibits the highest cell-type specificity in myoepithelial cells, making it a promising target for Sjogren syndrome research? Identify the validated therapeutic targets for Sjögren syndrome and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the myoepithelial cell-activated genes in PINNACLE, thereby defining the cell-type–specific targets for Sjögren syndrome. Compute the average embedding for this overlapping set and calculate the cosine similarity between this average embedding and each individual target. If one gene exhibits a significantly higher similarity compared to the others, nominate it as the top candidate, and provide a succinct, evidence-based justification for its biological relevance."
"['PPM1J', 'USP36', 'FKBP1A', 'DDAH2', 'CBFA2T3']",Sjogren syndrome,myoepithelial cell,FKBP1A,"Which gene among PPM1J, USP36, FKBP1A, DDAH2, and CBFA2T3 exhibits the most specific expression in myoepithelial cells for potential targeting in Sjögren’s syndrome?","Which gene among PPM1J, USP36, FKBP1A, DDAH2, and CBFA2T3 exhibits the most specific expression in myoepithelial cells for potential targeting in Sjögren’s syndrome? Identify the verified therapeutic targets for Sjögren syndrome and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which myoepithelial cell-activated genes in PINNACLE overlap with these targets to define the cell-type–specific therapeutic set. Compute the average embedding of this set as a reference and calculate the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['FITM2', 'MIF', 'ITGB5', 'SLC6A19', 'STIP1']",Sjogren syndrome,myoepithelial cell,MIF,"Among the genes FITM2, MIF, ITGB5, SLC6A19, and STIP1, which one demonstrates the highest specificity for myoepithelial cells relevant to targeting Sjogren syndrome?","Among the genes FITM2, MIF, ITGB5, SLC6A19, and STIP1, which one demonstrates the highest specificity for myoepithelial cells relevant to targeting Sjogren syndrome? Identify the validated therapeutic targets for Sjogren syndrome and collect their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the set of myoepithelial cell-activated genes from PINNACLE; this overlapping subset represents the cell-type–specific targets for the syndrome. Compute the average embedding for these overlapping genes as a reference, and then calculate the cosine similarity between this reference and each individual target’s embedding. If one gene shows significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['THRAP3', 'DARS2', 'PEX6', 'NDUFB7', 'JAK1']",Sjogren syndrome,myoepithelial cell,JAK1,"Which gene among THRAP3, DARS2, PEX6, NDUFB7, and JAK1 demonstrates the highest specificity for myoepithelial cells in the context of Sjogren syndrome?","Which gene among THRAP3, DARS2, PEX6, NDUFB7, and JAK1 demonstrates the highest specificity for myoepithelial cells in the context of Sjogren syndrome? Identify experimentally validated therapeutic targets for Sjogren syndrome and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which myoepithelial cell–activated genes in PINNACLE overlap with these targets, and compute the average embedding for this overlapping set. Calculate the cosine similarity between this average embedding and each individual target's embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based justification for its biological relevance."
"['ARHGEF39', 'FCGRT', 'TREX1', 'ZP3', 'CDIN1']",Sjogren syndrome,myoepithelial cell,FCGRT,"Among the genes ARHGEF39, FCGRT, TREX1, ZP3, and CDIN1, which one exhibits the highest specificity for expression in myoepithelial cells, making it the most promising target for investigating Sjogren's syndrome?","Among the genes ARHGEF39, FCGRT, TREX1, ZP3, and CDIN1, which one exhibits the highest specificity for expression in myoepithelial cells, making it the most promising target for investigating Sjogren's syndrome? Identify the validated therapeutic targets for Sjogren syndrome and extract their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the myoepithelial cell-activated genes within the same dataset. Compute the average embedding of this overlapping gene set and then calculate the cosine similarity between this reference embedding and the embedding of each individual target. Finally, if one gene shows a markedly higher similarity than the others, designate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['OPRPN', 'ARID3C', 'FCGRT', 'PCNT', 'TWNK']",Sjogren syndrome,myoepithelial cell,FCGRT,"Which gene among OPRPN, ARID3C, FCGRT, PCNT, and TWNK shows the most specific expression in myoepithelial cells for targeted intervention in Sjogren syndrome?","Which gene among OPRPN, ARID3C, FCGRT, PCNT, and TWNK shows the most specific expression in myoepithelial cells for targeted intervention in Sjogren syndrome? Identify the established therapeutic targets for Sjögren syndrome and extract their cell-type–specific embeddings from PINNACLE. Next, determine which myoepithelial cell-activated genes in PINNACLE overlap with these targets, forming the cell-type–specific target set for Sjögren syndrome. Calculate the average embedding for this set as a reference, then compute the cosine similarity between the reference and each target gene. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PCNX1', 'TNFAIP1', 'PPIA', 'ARID3A', 'PLPPR1']",Sjogren syndrome,myoepithelial cell,PPIA,"Which gene among PCNX1, TNFAIP1, PPIA, ARID3A, and PLPPR1 demonstrates the highest specificity for myoepithelial cells in the context of targeting Sjögren syndrome?","Which gene among PCNX1, TNFAIP1, PPIA, ARID3A, and PLPPR1 demonstrates the highest specificity for myoepithelial cells in the context of targeting Sjögren syndrome? Identify the verified therapeutic targets for Sjogren syndrome and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which myoepithelial cell-activated genes in PINNACLE overlap with these targets, and calculate the average embedding for this overlapping set. Then, compute the cosine similarity between this reference embedding and each individual target embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CYTH4', 'FKBP1A', 'HADHB', 'VAV2', 'ATP5F1D']",Sjogren syndrome,myoepithelial cell,FKBP1A,"Which gene—CYTH4, FKBP1A, HADHB, VAV2, or ATP5F1D—exhibits the highest specificity of expression in myoepithelial cells for Sjögren's syndrome targeting?","Which gene—CYTH4, FKBP1A, HADHB, VAV2, or ATP5F1D—exhibits the highest specificity of expression in myoepithelial cells for Sjögren's syndrome targeting? Identify experimentally verified therapeutic targets for Sjögren syndrome and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with genes activated in myoepithelial cells. For the overlapping genes, compute an average embedding as a reference and calculate the cosine similarity between this reference and each individual gene embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MCHR1', 'STRN', 'PRRX1', 'BDH2', 'JAK1']",Sjogren syndrome,myoepithelial cell,JAK1,"Which gene among MCHR1, STRN, PRRX1, BDH2, and JAK1 exhibits the highest specificity for myoepithelial cells, making it the best candidate for targeted intervention in Sjogren syndrome?","Which gene among MCHR1, STRN, PRRX1, BDH2, and JAK1 exhibits the highest specificity for myoepithelial cells, making it the best candidate for targeted intervention in Sjogren syndrome? Identify the validated therapeutic targets for Sjogren syndrome and retrieve their corresponding cell-type–specific embeddings from PINNACLE. Next, determine which genes activated in myoepithelial cells overlap with these targets, thereby defining the cell-type–specific targets for Sjogren syndrome. Compute the average embedding of this overlapping set and calculate the cosine similarity between this reference and each individual gene embedding. If one gene shows substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ALDH4A1', 'RUNX3', 'AFAP1L1', 'PDLIM5', 'HLA-B']",Sjogren syndrome,myoepithelial cell,HLA-B,"Which gene among ALDH4A1, RUNX3, AFAP1L1, PDLIM5, and HLA-B exhibits the highest myoepithelial cell specificity for potential targeting of Sjogren syndrome?","Which gene among ALDH4A1, RUNX3, AFAP1L1, PDLIM5, and HLA-B exhibits the highest myoepithelial cell specificity for potential targeting of Sjogren syndrome? Identify the verified therapeutic targets for Sjogren syndrome and obtain their cell-type–specific embeddings from PINNACLE. Then, determine which myoepithelial cell-activated genes in PINNACLE overlap with these targets to define a set of cell-type–specific therapeutic candidates. Compute the average embedding of this overlapping set and calculate the cosine similarity between this reference and each gene’s embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate, providing a concise, evidence-based rationale for its biological relevance."
"['CDA', 'FTSJ3', 'DPY30', 'MIF', 'STON1-GTF2A1L']",Sjogren syndrome,myoepithelial cell,MIF,"Which gene—CDA, FTSJ3, DPY30, MIF, or STON1-GTF2A1L—demonstrates the highest cell-type specificity in myoepithelial cells, thereby representing the optimal candidate target for Sjogren syndrome?","Which gene—CDA, FTSJ3, DPY30, MIF, or STON1-GTF2A1L—demonstrates the highest cell-type specificity in myoepithelial cells, thereby representing the optimal candidate target for Sjogren syndrome? Identify the confirmed therapeutic targets for Sjogren syndrome and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the set of myoepithelial cell–activated genes in PINNACLE to define the cell-type-specific targets for Sjogren syndrome. Compute the average embedding for this overlapping set, then calculate the cosine similarity between this average and each individual target’s embedding. If one gene exhibits substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['KDM4C', 'SRSF9', 'CFAP161', 'PDCD11', 'HLA-B']",Sjogren syndrome,myoepithelial cell,HLA-B,"Which gene among KDM4C, SRSF9, CFAP161, PDCD11, and HLA-B demonstrates the highest specificity for myoepithelial cells, thereby representing the optimal candidate for targeting Sjögren syndrome?","Which gene among KDM4C, SRSF9, CFAP161, PDCD11, and HLA-B demonstrates the highest specificity for myoepithelial cells, thereby representing the optimal candidate for targeting Sjögren syndrome? What are the verified therapeutic targets for Sjogren syndrome, and how can we retrieve their cell-type–specific embeddings from PINNACLE? Identify the subset of these targets that overlaps with myoepithelial cell-activated genes in PINNACLE, and compute the average embedding of this overlapping set as a reference. Then, calculate the cosine similarity between this reference embedding and each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['RBPMS', 'CRYBB1', 'TBXA2R', 'EIF2B2', 'FKBP1A']",Sjogren syndrome,myoepithelial cell,FKBP1A,"Which gene among RBPMS, CRYBB1, TBXA2R, EIF2B2, and FKBP1A demonstrates the highest cell-type specific expression in myoepithelial cells relevant to Sjogren syndrome?","Which gene among RBPMS, CRYBB1, TBXA2R, EIF2B2, and FKBP1A demonstrates the highest cell-type specific expression in myoepithelial cells relevant to Sjogren syndrome? Identify validated therapeutic targets for Sjögren syndrome and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine which myoepithelial cell–activated genes in PINNACLE overlap with these targets to define a set of cell-type–specific therapeutic candidates. Compute the average embedding of this overlapping set as a reference, then determine the cosine similarity between this reference and each individual target. If one gene shows a significantly higher similarity than all others, nominate it as the top candidate, and provide a concise, evidence-based explanation of its biological relevance."
"['RNF103', 'RXFP3', 'SMIM14', 'CMPK1', 'PPIA']",Sjogren syndrome,myoepithelial cell,PPIA,"Among the candidate genes—RNF103, RXFP3, SMIM14, CMPK1, and PPIA—which one exhibits the highest specificity in myoepithelial cells, making it the most promising target for therapeutic intervention in Sjogren's syndrome?","Among the candidate genes—RNF103, RXFP3, SMIM14, CMPK1, and PPIA—which one exhibits the highest specificity in myoepithelial cells, making it the most promising target for therapeutic intervention in Sjogren's syndrome? Retrieve the verified therapeutic targets for Sjögren syndrome and obtain their cell‐type–specific embeddings from the PINNACLE database. Identify which genes activated in myoepithelial cells overlap with these targets to define a set of cell‐type–specific targets for Sjögren syndrome. Calculate the average embedding of this overlapping set as a reference, then compute the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['RGS20', 'FCGRT', 'IL13RA2', 'WDR36', 'DNAJB14']",Sjogren syndrome,myoepithelial cell,FCGRT,"Which gene among RGS20, FCGRT, IL13RA2, WDR36, and DNAJB14 exhibits the highest specificity for myoepithelial cells, making it the strongest candidate for targeting in Sjögren’s syndrome?","Which gene among RGS20, FCGRT, IL13RA2, WDR36, and DNAJB14 exhibits the highest specificity for myoepithelial cells, making it the strongest candidate for targeting in Sjögren’s syndrome? Identify the verified therapeutic targets for Sjogren syndrome, and obtain their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the myoepithelial cell-activated genes from PINNACLE to define the cell-type–specific targets. Calculate the average embedding of this overlapping set as a reference, and compute the cosine similarity between this reference and each individual target. If one gene shows significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['FAM47A', 'JAK1', 'FAM199X', 'ZNF205', 'PIGY']",Sjogren syndrome,myoepithelial cell,JAK1,"Which gene among FAM47A, JAK1, FAM199X, ZNF205, and PIGY exhibits the greatest specificity for myoepithelial cells in the context of targeting Sjögren syndrome?","Which gene among FAM47A, JAK1, FAM199X, ZNF205, and PIGY exhibits the greatest specificity for myoepithelial cells in the context of targeting Sjögren syndrome? Identify the verified therapeutic targets for Sjögren’s syndrome and obtain their cell type-specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with the set of myoepithelial cell-activated genes identified in PINNACLE. Calculate the average embedding for this overlapping subset as a reference, then compute the cosine similarity of each individual target relative to this reference. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MIF', 'LIMA1', 'NINL', 'ZUP1', 'RGS4']",Sjogren syndrome,myoepithelial cell,MIF,"Among the genes MIF, LIMA1, NINL, ZUP1, and RGS4, which one exhibits the highest specificity for myoepithelial cells, making it the prime candidate for targeting Sjögren's syndrome?","Among the genes MIF, LIMA1, NINL, ZUP1, and RGS4, which one exhibits the highest specificity for myoepithelial cells, making it the prime candidate for targeting Sjögren's syndrome? Identify validated therapeutic targets for Sjogren syndrome and obtain their corresponding cell-type–specific embeddings from the PINNACLE dataset. Next, identify the overlap between these targets and the set of myoepithelial cell-activated genes in PINNACLE to define cell-type–specific targets. Compute the average embedding for this overlapping set, then calculate the cosine similarity between this reference and each individual therapeutic target. If one gene exhibits a significantly higher similarity than the others, designate it as the leading candidate and provide a concise, evidence-based rationale for its biological relevance."
"['C7orf31', 'JAK1', 'H3C7', 'CCDC7', 'HNRNPH3']",Sjogren syndrome,myoepithelial cell,JAK1,"Which gene among C7orf31, JAK1, H3C7, CCDC7, and HNRNPH3 exhibits the most specific expression in myoepithelial cells for potential targeting in Sjogren's syndrome?","Which gene among C7orf31, JAK1, H3C7, CCDC7, and HNRNPH3 exhibits the most specific expression in myoepithelial cells for potential targeting in Sjogren's syndrome? Identify the validated therapeutic targets for Sjogren syndrome and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with myoepithelial cell-activated genes in PINNACLE to establish a set of cell-type–specific targets for Sjogren syndrome. Compute the average embedding for these overlapping targets and calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological significance."
"['BDKRB2', 'DAZ4', 'ACKR1', 'GRIK2', 'FCGRT']",Sjogren syndrome,myoepithelial cell,FCGRT,"Among the genes BDKRB2, DAZ4, ACKR1, GRIK2, and FCGRT, which one exhibits the highest specificity for myoepithelial cells, making it the most promising candidate for targeted therapy in Sjögren's syndrome?","Among the genes BDKRB2, DAZ4, ACKR1, GRIK2, and FCGRT, which one exhibits the highest specificity for myoepithelial cells, making it the most promising candidate for targeted therapy in Sjögren's syndrome? Identify the verified therapeutic targets for Sjögren syndrome and obtain their cell-type-specific embeddings from PINNACLE. Next, determine the overlap between these targets and the myoepithelial cell-activated genes in PINNACLE to define a set of cell-type-specific therapeutic targets. Calculate the average embedding for this set and then compute the cosine similarity between each individual target embedding and this average. If one gene exhibits a markedly higher similarity than the others, nominate it as the leading candidate and provide a concise, evidence-based explanation of its biological relevance."
"['SMARCC2', 'MORN5', 'IPO9', 'CYP19A1', 'MIR451A']",Sjogren syndrome,fibroblast,SMARCC2,"Among the genes SMARCC2, MORN5, IPO9, CYP19A1, and MIR451A, which exhibits the highest cell-type specificity in fibroblasts in relation to Sjogren syndrome?","Among the genes SMARCC2, MORN5, IPO9, CYP19A1, and MIR451A, which exhibits the highest cell-type specificity in fibroblasts in relation to Sjogren syndrome? Identify the verified therapeutic targets for Sjogren syndrome within the PINNACLE dataset and retrieve their cell-type–specific embeddings. Next, determine the intersection between these targets and fibroblast-activated genes to establish a set of cell-type–specific targets. Compute the average embedding for this set and calculate the cosine similarity between this reference and each individual gene's embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the prime candidate and provide a concise, evidence-based explanation for its biological relevance."
"['ACTR6', 'GPAM', 'PLA2G4B', 'RNF170', 'PPIA']",Sjogren syndrome,fibroblast,PPIA,"Which gene among ACTR6, GPAM, PLA2G4B, RNF170, and PPIA exhibits the highest fibroblast-specific expression relevant to targeting Sjogren’s syndrome?","Which gene among ACTR6, GPAM, PLA2G4B, RNF170, and PPIA exhibits the highest fibroblast-specific expression relevant to targeting Sjogren’s syndrome? Identify the experimentally validated therapeutic targets for Sjögren syndrome and extract their cell-type–specific embeddings from the PINNACLE dataset. Then, determine which of the fibroblast-activated genes in PINNACLE overlap with these targets to define a candidate set. Compute the average embedding of this set and calculate the cosine similarity of each individual candidate gene to this average. If one gene exhibits a substantially higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based rationale for its biological relevance."
"['NDUFS8', 'STAT1', 'SETD3', 'FGF19', 'LOXL3']",Sjogren syndrome,fibroblast,STAT1,"Among the genes NDUFS8, STAT1, SETD3, FGF19, and LOXL3, which one demonstrates the highest fibroblast-specific expression profile for potential targeting in Sjögren’s syndrome?","Among the genes NDUFS8, STAT1, SETD3, FGF19, and LOXL3, which one demonstrates the highest fibroblast-specific expression profile for potential targeting in Sjögren’s syndrome? Identify the verified therapeutic targets for Sjogren syndrome and extract their cell-type–specific embeddings from PINNACLE. Next, determine which fibroblast-activated genes in PINNACLE overlap with these targets to establish the cell-type–specific targets for Sjogren syndrome. Compute the average embedding of this overlapping set and calculate the cosine similarity between this average and each individual target embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['DDX6', 'TLR4', 'OPRD1', 'METTL27', 'TMEM258']",Sjogren syndrome,fibroblast,DDX6,"Among DDX6, TLR4, OPRD1, METTL27, and TMEM258, which gene exhibits the most pronounced fibroblast-specific expression, making it the most promising candidate for targeting in Sjögren syndrome research?","Among DDX6, TLR4, OPRD1, METTL27, and TMEM258, which gene exhibits the most pronounced fibroblast-specific expression, making it the most promising candidate for targeting in Sjögren syndrome research? Identify the validated therapeutic targets for Sjogren syndrome and extract their corresponding cell-type–specific embeddings from PINNACLE. Then, find the overlapping set between these targets and the fibroblast-activated genes identified in PINNACLE. Calculate the average embedding of this overlapping set as a reference, and determine the cosine similarity between the reference and each individual target’s embedding. If one gene exhibits a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['KLHDC3', 'KDM4D', 'BAZ2A', 'WASHC2C', 'RACK1']",Sjogren syndrome,fibroblast,BAZ2A,"Among the genes KLHDC3, KDM4D, BAZ2A, WASHC2C, and RACK1, which exhibits the highest fibroblast-specific expression, making it the most promising candidate as a therapeutic target for Sjögren's syndrome?","Among the genes KLHDC3, KDM4D, BAZ2A, WASHC2C, and RACK1, which exhibits the highest fibroblast-specific expression, making it the most promising candidate as a therapeutic target for Sjögren's syndrome? Identify the validated therapeutic targets for Sjogren syndrome using cell-type–specific embeddings from PINNACLE, and determine which of these targets overlap with fibroblast-activated genes. Compute the average embedding from this overlapping set and calculate the cosine similarity between the average and each target. If one gene exhibits a notably higher similarity than the others, nominate it as the primary candidate and provide a concise, evidence-based rationale for its biological relevance."
"['KRTAP5-11', 'RCN1', 'KRTAP9-3', 'FAM27E3', 'TFPI']",Sjogren syndrome,fibroblast,RCN1,"Which gene among KRTAP5-11, RCN1, KRTAP9-3, FAM27E3, and TFPI exhibits the highest fibroblast-specific expression for targeting Sjögren syndrome?","Which gene among KRTAP5-11, RCN1, KRTAP9-3, FAM27E3, and TFPI exhibits the highest fibroblast-specific expression for targeting Sjögren syndrome? Identify the validated therapeutic targets for Sjogren syndrome and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with fibroblast-activated genes in PINNACLE. Compute the average embedding for the overlapping set, then calculate the cosine similarity between this reference embedding and each individual target’s embedding. If one gene exhibits a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['FKBP1A', 'AP2B1', 'NEK3', 'NDUFC2', 'TMUB2']",Sjogren syndrome,fibroblast,FKBP1A,"Which gene among FKBP1A, AP2B1, NEK3, NDUFC2, and TMUB2 exhibits the highest fibroblast-specific expression for potential targeting in Sjögren's syndrome?","Which gene among FKBP1A, AP2B1, NEK3, NDUFC2, and TMUB2 exhibits the highest fibroblast-specific expression for potential targeting in Sjögren's syndrome? Identify validated therapeutic targets for Sjogren syndrome and obtain their cell-type–specific embeddings from PINNACLE. Then, determine which of these targets overlap with fibroblast-activated genes in PINNACLE to establish a refined set of cell-type–specific targets. Compute the average embedding for this overlapping set and calculate the cosine similarity between this average and each individual target’s embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the prime candidate and provide a concise, evidence-based rationale for its biological relevance."
"['GAS2', 'NR3C1', 'MED30', 'TNNI2', 'PRDM4']",Sjogren syndrome,fibroblast,NR3C1,"Among the genes GAS2, NR3C1, MED30, TNNI2, and PRDM4, which one exhibits the highest fibroblast-specific expression relevant for targeting Sjogren syndrome?","Among the genes GAS2, NR3C1, MED30, TNNI2, and PRDM4, which one exhibits the highest fibroblast-specific expression relevant for targeting Sjogren syndrome? Identify the verified therapeutic targets for Sjogren syndrome and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the fibroblast-activated genes in PINNACLE. Compute the average embedding of this overlapping set as a reference, and then calculate the cosine similarity between the reference and each individual target embedding. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['C12orf40', 'TOP2A', 'HLA-DRA', 'AURKB', 'NAXD']",Sjogren syndrome,fibroblast,HLA-DRA,"Among the genes C12orf40, TOP2A, HLA-DRA, AURKB, and NAXD, which one shows the highest fibroblast-specific expression in the context of Sjogren syndrome and represents the most promising single candidate for targeted study?","Among the genes C12orf40, TOP2A, HLA-DRA, AURKB, and NAXD, which one shows the highest fibroblast-specific expression in the context of Sjogren syndrome and represents the most promising single candidate for targeted study? Identify validated therapeutic targets for Sjogren syndrome and obtain their cell type–specific embeddings from PINNACLE. Next, determine which fibroblast-activation genes in PINNACLE overlap with these targets; this overlapping set represents the cell type–specific candidates for Sjogren syndrome. Calculate the average embedding for this set and then compute the cosine similarity between this reference and each individual candidate gene. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SLC22A24', 'XYLB', 'RPS10P5', 'TREX1', 'IFNAR1']",Sjogren syndrome,fibroblast,IFNAR1,"Among the genes SLC22A24, XYLB, RPS10P5, TREX1, and IFNAR1, which one exhibits the highest fibroblast-specific expression relevant to targeting Sjögren’s syndrome?","Among the genes SLC22A24, XYLB, RPS10P5, TREX1, and IFNAR1, which one exhibits the highest fibroblast-specific expression relevant to targeting Sjögren’s syndrome? Identify the verified therapeutic targets for Sjogren syndrome and retrieve their cell type–specific embeddings from the PINNACLE database. Next, determine which targets overlap with fibroblast-activated genes in PINNACLE. Compute the average embedding for this overlapping set as a reference, then calculate the cosine similarity between each individual target’s embedding and the reference. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based justification of its biological relevance."
"['DNAJA2', 'MRPL50', 'HLA-B', 'BEST3', 'FAT2']",Sjogren syndrome,fibroblast,HLA-B,"Among the genes DNAJA2, MRPL50, HLA-B, BEST3, and FAT2, which one exhibits the highest fibroblast-specific expression relevant to targeting Sjogren syndrome?","Among the genes DNAJA2, MRPL50, HLA-B, BEST3, and FAT2, which one exhibits the highest fibroblast-specific expression relevant to targeting Sjogren syndrome? Identify validated therapeutic targets for Sjögren syndrome and extract their cell-type-specific embeddings from PINNACLE. Next, determine which of these targets overlap with fibroblast-activated genes in PINNACLE to define a cell-type–specific target set for Sjögren syndrome. Compute the average embedding of this set to establish a reference profile, then calculate the cosine similarity between this reference and each individual target embedding. If one gene shows a substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based justification for its biological relevance."
"['GTF2I', 'ANKRD52', 'TRIM13', 'COL4A5', 'SEC14L1']",Sjogren syndrome,fibroblast,GTF2I,"Which gene among GTF2I, ANKRD52, TRIM13, COL4A5, and SEC14L1 exhibits the highest fibroblast-specific expression relevant to targeting Sjogren's syndrome?","Which gene among GTF2I, ANKRD52, TRIM13, COL4A5, and SEC14L1 exhibits the highest fibroblast-specific expression relevant to targeting Sjogren's syndrome? Identify the verified therapeutic targets for Sjögren syndrome and obtain their cell-type–specific embeddings from PINNACLE. Then, determine which of the fibroblast-activated genes in PINNACLE overlap with these targets, thereby defining the cell-type–specific targets for Sjögren syndrome. Calculate the average embedding for this overlapping set and assess the cosine similarity between this average and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SPRR2C', 'CLCF1', 'NFKB2', 'JAK1', 'ACBD7']",Sjogren syndrome,fibroblast,JAK1,"Which gene among SPRR2C, CLCF1, NFKB2, JAK1, and ACBD7 demonstrates the highest fibroblast-specific expression, making it the most promising candidate for targeted intervention in Sjögren's syndrome?","Which gene among SPRR2C, CLCF1, NFKB2, JAK1, and ACBD7 demonstrates the highest fibroblast-specific expression, making it the most promising candidate for targeted intervention in Sjögren's syndrome? Identify the verified therapeutic targets for Sjögren syndrome and retrieve their cell-type–specific embeddings from the PINNACLE database. Determine the intersection between these targets and the fibroblast-activated gene set in PINNACLE to define the cell-type–specific targets for Sjögren syndrome. Calculate the average embedding of this intersected set, then compute the cosine similarity between this reference and each individual target. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CKMT2', 'LOX', 'NDUFB1', 'HLA-B', 'IFITM5']",Sjogren syndrome,fibroblast,HLA-B,"Which gene among CKMT2, LOX, NDUFB1, HLA-B, and IFITM5 demonstrates the highest fibroblast-specific expression, making it the prime candidate for targeting Sjogren syndrome?","Which gene among CKMT2, LOX, NDUFB1, HLA-B, and IFITM5 demonstrates the highest fibroblast-specific expression, making it the prime candidate for targeting Sjogren syndrome? Identify the validated therapeutic targets for Sjögren syndrome and obtain their cell-type–specific embeddings from the PINNACLE dataset. Next, determine the overlap between these targets and fibroblast-activated genes in PINNACLE to define the cell-type–specific targets. Compute the average embedding of this overlapping set, then calculate the cosine similarity between this average and each individual target’s embedding. If one gene demonstrates a markedly higher similarity than the others, nominate it as the primary candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PWWP3A', 'CALCB', 'ZFAND2B', 'BAZ2A', 'WNT11']",Sjogren syndrome,fibroblast,BAZ2A,"Among the genes PWWP3A, CALCB, ZFAND2B, BAZ2A, and WNT11, which one exhibits the most fibroblast-specific expression profile relevant to targeting Sjögren syndrome?","Among the genes PWWP3A, CALCB, ZFAND2B, BAZ2A, and WNT11, which one exhibits the most fibroblast-specific expression profile relevant to targeting Sjögren syndrome? Identify the validated therapeutic targets for Sjogren syndrome and obtain their cell-type–specific embeddings from the PINNACLE dataset. From these targets, determine which ones overlap with fibroblast-activated genes listed in PINNACLE. Compute the average embedding for the overlapping genes and calculate the cosine similarity between this average and each individual target gene’s embedding. If one gene exhibits a significantly higher cosine similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['CCDC174', 'AUP1', 'HLA-DRA', 'NXF2', 'FLII']",Sjogren syndrome,fibroblast,HLA-DRA,"Which gene among CCDC174, AUP1, HLA-DRA, NXF2, and FLII exhibits the highest fibroblast-specific expression relevant to Sjogren's syndrome?","Which gene among CCDC174, AUP1, HLA-DRA, NXF2, and FLII exhibits the highest fibroblast-specific expression relevant to Sjogren's syndrome? Identify the verified therapeutic targets for Sjögren syndrome and retrieve their cell-type–specific embeddings from PINNACLE. Determine the subset that overlaps with fibroblast-activated genes in PINNACLE to define the cell-type–specific targets for Sjögren syndrome. Compute the average embedding of these overlapping genes as a reference vector, then calculate the cosine similarity between this reference and each individual target. If one gene shows significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MAB21L3', 'GTF2I', 'C19orf54', 'TMEM237', 'NUDT10']",Sjogren syndrome,fibroblast,GTF2I,"Among the following genes—MAB21L3, GTF2I, C19orf54, TMEM237, and NUDT10—which exhibits the highest fibroblast-specific expression and represents the most promising candidate target for Sjögren's syndrome?","Among the following genes—MAB21L3, GTF2I, C19orf54, TMEM237, and NUDT10—which exhibits the highest fibroblast-specific expression and represents the most promising candidate target for Sjögren's syndrome? Identify the verified therapeutic targets for Sjögren syndrome and retrieve their cell-type–specific embeddings from PINNACLE. Determine which of these targets overlap with fibroblast-activated genes in PINNACLE. For the overlapping set, compute the average embedding as a reference and calculate the cosine similarity between this reference and each individual gene embedding. If one gene consistently exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['RNPEP', 'RRH', 'ALG9', 'DDX6', 'AMACR']",Sjogren syndrome,fibroblast,DDX6,"Which gene among RNPEP, RRH, ALG9, DDX6, and AMACR exhibits the highest fibroblast-specific expression relevant for targeting Sjögren's syndrome?","Which gene among RNPEP, RRH, ALG9, DDX6, and AMACR exhibits the highest fibroblast-specific expression relevant for targeting Sjögren's syndrome? Identify validated therapeutic targets for Sjögren syndrome and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of the fibroblast-activated genes in PINNACLE overlap with these targets, defining these as the cell-type–specific targets for Sjögren syndrome. Compute the average embedding for these overlapping genes and calculate the cosine similarity between this average and the embedding of each individual target. If one gene exhibits a substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ELOVL1', 'JAK1', 'YEATS4', 'PLAGL1', 'GRIK3']",Sjogren syndrome,fibroblast,JAK1,"Among the genes ELOVL1, JAK1, YEATS4, PLAGL1, and GRIK3, which exhibits the highest fibroblast-specific expression and may serve as the optimal therapeutic target for Sjögren's syndrome?","Among the genes ELOVL1, JAK1, YEATS4, PLAGL1, and GRIK3, which exhibits the highest fibroblast-specific expression and may serve as the optimal therapeutic target for Sjögren's syndrome? Identify the verified therapeutic targets for Sjogren syndrome and retrieve their cell-type specific embeddings from PINNACLE. Next, determine which of these targets overlap with fibroblast-activated genes to establish a set of cell-specific targets. Compute the average embedding for these overlapping genes as a reference, then calculate the cosine similarity between this reference embedding and each individual target’s embedding. If one gene exhibits a considerably higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['BLM', 'SMCR8', 'VSIG4', 'RCN1', 'OR8D2']",Sjogren syndrome,fibroblast,RCN1,"Which gene among BLM, SMCR8, VSIG4, RCN1, and OR8D2 demonstrates the highest cell-type specificity in fibroblasts for potential targeting in Sjogren's syndrome?","Which gene among BLM, SMCR8, VSIG4, RCN1, and OR8D2 demonstrates the highest cell-type specificity in fibroblasts for potential targeting in Sjogren's syndrome? Identify validated therapeutic targets for Sjogren syndrome and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with fibroblast-activated genes in PINNACLE to establish a set of cell-type–specific targets for the syndrome. Calculate the average embedding of this overlapping set as a reference and compute the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
